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Biflavonoids form a ubiquitous class of compounds in nature, which are well
known for their numerous medicinal benefits. Biflavonoids such as chamaejasmine and
isochamaejasmine have been shown to exhibit pharmacological activity such as
anitidiabetic, anti-malaria, anti- HIV, anticancer etc. Biflavanones, chamaejasmine and
isochamaejasmine are dimers of the flavanone narigenin at the C-3 position, which gives
them a rare 3/3″ C – C linkage. They are structurally similar in that they both have four
stereocenters. The difference between these two compounds is the stereochemistry at the
C-2″ and C-3″. In this study, installation of each of these stereocenters will be targeted at
different stages of the synthesis.
Installation of the stereocenters at C-2 and C-3 was achieved through the
cyclopropanation of a 2-aryl-2H-chromene, followed by the tin (II) triflate catalyzed
rearrangement of the cyclopropane into a gamma-lactone. This gamma-lactone provided
the core structure for one of the flavanone units in the targeted biflavonoids, as well as
providing the building block for the second flavanone unit.

For the construction of the second flavanone unit the gamma-lactone was
transformed into a chalcone precursor, which served as the platform for the installation of
the other two stereocenters in the biflavonoids. The construction of the chalcone
precursor was achieved first through the synthesis of an alpha-benzylidene lactone.
Several attempts were made to open this alpha-benzylidene lactone via the addition of an
aryllithium, which proved to be a challenge. This problem was resolved through the
opening of the alpha-benzylidene lactone via reduction with Red-Al, subsequent
formation of an aldehyde, and then addition of the aryllithium to the aldehyde. Successful
synthesis of the chalcone precursor was achieved through the oxidation of the product of
the aryllithium addition, albeit in a modest yield (43 %).
Herein, studies related towards the synthesis of chamaejasmine and
isochamaejasmine are presented.

Keywords: biflavonoids, biflavanones, chamaejasmine, isochamaejasmine,
cyclopropanation
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INTRODUCTION

Biflavonoids
Biflavonoids are polyphenolic compounds that form an important class of
compounds in nature. They are basically dimers of flavonoids (chalcones, flavones,
flavanones, flavanols, etc.) linked by either a C – C or a C – O – C linkage (Figure 1.1).
Since the connecting linkage may occur at several different positions a wide variety of
flavonoid-flavonoid combinations exist. However, biflavonoids are prevalent in only a
few plant species. Biflavonoids are of growing interest in the medicinal field due to their
exhibition of a wide spectrum of pharmacological benefits which includes, but are not
limited to, antioxidant,1-2 anticancer,3-5 anti-inflammatory,6-7 and antiviral. 8-9

Figure 1.1

Basic scaffold of flavonoids and biflavonoids
1

These bioactive compounds, though not widely distributed, occur in a wide
variety of fruits, vegetables and plants. Since the isolation of the first biflavonoid,
ginkgetin, from the leaves of the tree Ginkgo biloba L., the number of biflavonoids
isolated and characterized has significantly grown.10
Stellera chamaejasme L. is one plant from which these biflavonoids have been
isolated. Commonly known as Langdu in Chinese traditional herbal medicine, it is widely
distributed in the northern and southwestern parts of China and Nepal and has been used
in the treatment of scabies, skin ulcers, solid tumors and tuberculosis.11-12 These known
therapeutic effects have led to great interest into the isolation of several bioactive
compounds found in Stellera chamaejasme L.13-17 The biflavonoids, chamaejasmine and
isochamaejasmine, which contain the rare 3, 3″ – linkage between dimers, are two such
compounds isolated from the roots of Stellera chamaejasme L. Typical C-3/C-3″
biflavonoids like these have been found to have various biological activities such as
antifungal,18 anticancer,19 antiviral (HIV20 & hepatitis B14) and antimalarial.21
Chamaejasmine
Chamaejasmine was first isolated from Stellera Chamaejasme L. in 1979 by Hung
and Zhang.22 Subsequently, several 3/3” biflavonoids, including its meso isomer
isochamaejasmine,23 have been isolated from Stellera Chamaejasme L., as well as other
plant species. Chamaejasmine 1 is a C2 symmetric dimer of the flavonoid naringenin 2 at
C-3 with four stereocenters, having the geometry of trans- trans at C-2/C-3 and C-2″/ C3″ (Figure 1.2).

2

Figure 1.2

Structures of chamaejasmine 1 and naringenin 2

Chamaejasmine, is of significant medicinal interest due to its demonstrated
biological activities.24-29 It has been shown to be active against several cancer cell lines.
In one case it was shown to inhibit cell proliferation (IC50 = 4 –16 µm) when its
anticancer activity was evaluated against the breast cancer line, MDA-MB-231.27
Screening chamaejasmine against the human lung adenocarcinoma, demonstrated its
ability to inhibit the growth of A549 cells in a time dependent manner, with an IC50 value
of 7.72 µM after 72 hrs of treatment.26 Both of these preceding bioactivities of
chamaejasmine strongly suggests that it can be used as a chemotherapeutic agent.
Chamaejasmine has not only been shown to be an anticancer agent but also has been
shown to inhibit aldose reductase,28 a key role player in the complications, like
neuropathy and retinopathy, associated with diabetes.
Bao-Chun et al. were able to achieve the first synthesis of dl- chamaejasmine via
a biomimetric synthetic strategy (Scheme 1.1).30 In this approach, 2′-hydroxy
acetophenone 3 was treated with p- anisaldehyde in the presence of potassium hydroxide
to produce 2′- hydroxy chalcone 4. The chalcone was then cyclized to flavanone 5 with
the use of sodium acetate. Treatment of flavanone 5 with N-iodosuccinimide yielded 33

iodoflavanone 6, the key intermediate in the synthesis. The key step in the synthesis was
achieved by the dimerization of 6 in the presence of lanthanum. This reductive
dimerization yields the racemic-chamaejasmine hexamethyl ether 7 in 10 % yield as well
as several by-products. The major of these isolable products (Figure 1.3) were chalcone 4
(25 %), flavone 8 (20 %) and flavanone 5 (5 %). Global demethylation of 7 with excess
tribromide boron yielded the desired dl- chamaejasmine with an overall yield of 22 %.

Biomimetic synthesis of racemic chamaejasmine

Figure 1.3

By-products from the reductive dimerization

4

While this synthetic route to chamaejasmine may be considered to be a concise
route (5 steps) it suffers from a poor overall yield. Our approach, as will be discussed in a
subsequent section, will allow for the synthesis of chamaejasmine as well as, the
synthesis of its meso- isomer isochamaejasmine.
Isochamaejasmine
Isochamaejasmine 9 (Figure 1.4) is one of the stereoisomers of chamaejasmine,
differing only by the stereochemistry at C-2″ and C-3″. Like its isomer chamaejasmine, it
has been of great interest in the medicinal field.31-33 Isochamaejasmine has been found to
have antimicrobial and antiparasitic activity. In the screening of it against the
Plasmodium falciparum, a species that causes malaria, it was found to have moderate
antiplasmodial activity with an IC50 of 7.3 ± 3.8 µm, while having a relatively low
cytotoxicity (CC50 29.0 ± 10.9 µm).33 Isochamaejasmine, has also been shown to have
anticancer activity: it has been found to stimulate the activation of NF-κB in the human
cervical cancer cell line HeLA, with an EC50 of 3.23 µm, independently of FPRL1.32
This activation of NF-κB indicates that isochamaejasmine can affect cancer cells while
having little effect on normal cells; a key problem with prevalent aniticancer drugs.

Figure 1.4

Structure of isochamaejasmine
5

Unlike chamaejasmine, isochamejasmine has not been synthesized previously.
Efforts made during this study were targeted towards the synthesis of both of these
bioactive compounds via a common intermediate (section 1.4). Synthesis of these
molecules will allow for the greater exploration of their medicinal benefits, since
isolation of these compounds is extremely tedious. A typical isolation protocol34 of these
compounds involves several extraction procedures, using a variety of solvent conditions,
followed by preparative HPLC and then preparative TLC or flash column
chromatography. This protocol yields ~10 mg of the desired compound after starting with
1 kg of the plant material. Thus synthesis of these compounds will provide means to
generate greater quantities of these compounds, in a less tedious manner, which could
lead to further exploration of their medicinal properties.
Retrosynthesis
As discussed in the previous section chamaejasmine and isochamaejasmine by
their respective stereochemistry at C-2″ and C-3″ (Figure 1.5). It is envisioned that these
stereocenters (C-2″ and C-3″) may be set by the cyclization of chalcone precursors 10
(Scheme 1.2).

Figure 1.5

Structural differences between chamaejasmine and isochamaejasmine
6

Using the notion that chalcones tend to cyclize with complete trans-selectivity,35 it
can be hypothesized that different geometric configurations of the enone moiety of
chalcone precursor 10 would result in the formation of different products. That is, the
cyclisation of Z or E-chalcones would result in the formation of trans products with
opposite stereochemistry at C-2″ and C-3″.

Chalcone precursor for the synthesis of chamaejasmine and
isochamaejasmine

Utilizing a retrosynthetic approach (Scheme 1.3) the chalcone precursor can be
synthesized via lithiation of α-benzylidene lactone 11 using known aryllithium 12. The αbenzylidene lactone can be synthesized by a Horner – Wadsworth – Emmons (HWE)
olefination. It is at this stage of the synthesis that the geometric configuration of the
chalcone will be determined. Yu and coworkers have demonstrated that the
stereochemical outcome of a HWE olefination on α-phosphono lactones can be controlled
by the application of different reaction conditions.36 Z-Olefins were selectively obtained
(90:1, Z/E) by treatment of α-phosphono lactones with KHMDS and then rapidly
warming to room temperature. On the other hand, applying the same conditions but
warming slowly to room temperature resulted in selective formation of E-olefins (~70:1,

7

E/Z). Successful application of these reaction conditions to our α-phosphono lactone
would provide the necessary framework for our E/Z-desired chalcone precursor.

Proposed retrosynthetic approach to chalcone precursor

The α-phosphono lactone 13 required for this HWE olefination can be prepared
by the rearrangement of cyclopropane 14 via a γ- lactonization reaction. Methodology
developed within our laboratory has demonstrated that 2-aryl cyclopropanes rearrange37
to γ- lactones in decent yields (53- 75%) by treatment with a Lewis acid, such as
Sn(OTf)2. 2-Aryl cyclopropane 14 may be synthesized via the cyclopropanation of 2aryl-2H-chromene 15. It has been demonstrated that cyclopropanation of 2-aryl-2Hchromenes leads to exclusive formation of a single diastereomer.38 In this
diastereoselective cyclopropanation the cyclopropane adds anti to the aryl group,
resulting in a trans configuration (Figure 1.6). By successfully applying these conditions
to our chromene, stereocenters at C-2 and C-3 will be installed.

8

Figure 1.6

Crystal structure of typical cyclopropane adapted from ref.38

The chromene, a well-known synthetic scaffold, may be synthesized from the
required chalcone in a one pot protocol developed by Ashihara and coworkers.39
The ensuing chapters focus on efforts made towards the synthesis of the desired
chalcone precursor, as previously described. In the final section of chapter 2, the
hypothesis that E/Z-chalcones results in different products, thereby yielding either
chamaejasmine or isochamaejasmine, is evaluated.
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RESULTS AND DISCUSSION

Synthesis of Chromene
Chromenes (2H-benzopyran derivatives) are privileged scaffolds in drug
discovery, due to their occurance to a wide array of bioactive natural products.1-3 In our
study, towards the synthesis of isochamaejasmine as chamaejasmine, the chromene will
serve as the building block for one of the flavanone units found in these biflavonoids.
Chromene 15 will be synthesized via the cyclisation of chalcone 16, which in turn will be
synthesized via a Claisen-Schmidt condensation reaction. (Scheme 2.1)

Retrosynthetic analysis of chromene 15

Prior to synthesizing chalcone 16, several 2′-hydroxyacetophenones were
protected (Table 2.1). The protective group utilized was initially selected based on: 1)
relative ease of removal; a task that will be essential in the final stages of the synthesis of
these biflavonoids and 2) the ability to survive a multi-step synthesis. Preparation of the
13

respective 2′-hydroxyacetophenone were all conducted by the treatment of commercially
available 2′,4′,6′-trihydroxyacetophenone with a base in the presence of the respective
alkyl halide using established literature procedures,4-6 yielding the protected 2′-hydroxy
acetophenones 17a-c in good to excellent yields (70– 87 %).
Protection of 2′-hydroxyacetophenone

Product
R
% Yield
Bn
71
17a
MOM
70
17b
Me
87
17c

With the protected 2′-hydroxyacetophenones in hand, a Claisen-Schmidt
condensation reaction was conducted to form 2′-hydroxychalcones 16a-c (Table 2.2). The
methyl-protected chalcone 16c was synthesized under standard conditions of mixing the
acetophenone and the corresponding, commercially available benzaldehyde 18 in ethanol,
in the presence of a large excess of 60 % KOH solution. For entries 16a and 16b, an
alternate procedure had to be used for the synthesis since the respective acetophenones
were insoluble in ethanol. These chalcones were successfully synthesized by refluxing of
corresponding acetophenone and the benzaldehyde in DMF, in the presence of NaH.

14

Synthesis of 2′-hydroxychalcones

Product
R
R1 % Yield
Bn
Bn
88
16a
MOM Bn
47
16b
Me Me
83
16c

The chalcones were then converted into the corresponding 2-aryl-2H-chromenes
by the reduction of the carbonyl group followed by cyclization (Table 2.3). This
conversion was conducted by refluxing the chalcone in a 2:1 mixture of THF:EtOH in the
presence of NaBH4.7 This protocol is preferred to the alternate methods of 2-aryl-2Hchromene synthesis since the chromene is obtained in one step and the reaction is
typically completed within 30 mins to 1 hour. The chromenes were prepared in decent
yields using this method, with the exception of the MOM-protected chromene (Table 2.3,
entry 2), which decomposed rapidly during purification, even when purification was
conducted using neutral or basic alumina.
Synthesis of 2-aryl-2H-chromenes

Entry Product
R
R1 % Yield
15a
Bn
Bn
53
1
15b
MOM Bn
11
2
15c
Me Me
73
3

15

Chromenes have a tendency to decompose quickly,8 owing to their susceptibility
to oxidation; thus work- up and purification were done as quickly as possible.
Furthermore, synthesized chromenes were used immediately for the next stage of the
synthesis. If the chromene needed to be stored, it was stored at low temperatures (-5 to 10 oC) and was used within 3-5 days.
Synthesis of α-phosphono lactone 13
Once the chromene had been synthesized, synthesis of α-phosphono lactone 13
was attempted. Two approaches were considered in the formation of 13 (Scheme 2.2). In
both approaches the chromene would be converted to a cyclopropane, which will then
undergo a rearrangement reaction to produce a γ-lactone. The approaches differ by the
choice of diazo derivative that will be used for the cyclopropanation reaction. If route 1
was successful, it would produce a direct route to the α-phosphono lactone, through the
cyclopropanation of the chromene, followed by the rearrangement of that cyclopropane.
However, if route 1 is unsuccessful in yielding the desired product, the α-phosphono
lactone may be obtained by an indirect route (route 2). In route 2, following the
rearrangement reaction a decarboxylation would be necessary prior to the synthesis of the
α-phosphono lactone.

16

Approach to α-phosphono lactone

Prior to conducting the cyclopropanation reaction the two different diazos were
prepared via a Regitz diazotization,9 by treating the respective commercially available
starting material with p-acetamidobenzenesulfonyl azide (Table 2.4).
Synthesis of diazo

Diazo
X
% Yield
CO2Me
87
19a
54
19b PO(OEt)2

With the diazo derivatives in hand the cyclopropanation reactions were then
conducted via route 2, using optimized conditions of a methodology developed in our
lab.10 Chromenes 15a-c were treated with diazo derivative 19a in the presence of Rh2(sTBSP)4 (Table 2.5). This reaction was conducted by the slow addition of a solution of the
diazo derivative to a solution of the respective chromene and the catalyst. Addition of the
17

diazo derivative too quickly or too slowly leads to excessive dimerization of the diazo
derivative or decomposition of the chromene respectively.
This reaction was first attempted using the benzyl-protected chromene. The
benzyl group was the first choice of protective group due to its ability to be cleaved under
neutral conditions (reduction with H2 gas over Pd/C catalyst), thereby eliminating the risk
of the deprotection step interfering with other functional groups within the compound.
However, this reaction was unsuccessful (Table 2.5, entry 1), since only dimerized
product, the chromene and decomposed chromene were recovered from the reaction. The
lack of reactivity of the diazo towards the benzyl-protected chromene could be attributed
to the bulkiness of the benzyl protective group and its ability to freely rotate. These
attributes possibly lead to an unfavorable interaction between the chromene and the
incoming rhodium carbenoid species.
The protective group was then changed to a smaller group that could just as
easily be cleaved, using relatively mild conditions. Therefore, the next reaction was
conducted using the MOM-protected chromene 15b. Unfortunately, the same results were
obtained (Table 2.5, entry 3). These results could be explained for the same reasons as for
15a, as well as the fact that this chromene is much more unstable than the others (only
isolated in 11 % yield, Table 2.3). As a result of instability it is possible that the rate of
chromene decomposition may also play a role in the lack of reactivity.
Next, the cyclopropanation reaction was attempted using methyl-protected
chromene 15c, which contains the smallest protective group (Table 2.5, entry 4).
Gratifyingly, success was achieved as the desired cyclopropane 14d was attained in a
64 % yield as a single diastereomer. As explained in section 1.4, the crystal structure
18

obtained from these types of cyclopropanes indicates that the cyclopropane ring adds anti
to the aryl group at the 2- position of the pyran- moiety.11 This successful
cyclopropanation reaction therefore installs the chiral centers present in the targeted
biflavonoids at C-2 and C-3.
Cyclopropanation of 2H-chromenes

Entry Product R1
R
X
Catalyst
Solvent % Yield
14b
Bn
Bn
CO2Me Rh2(S-TBSP)4 DCM
---a
1
14c
Bn MOM CO2Me Rh2(S-TBSP)4 DCM
---a
2
14d
Me Me
CO2Me Rh2(S-TBSP)4 DCM
64
3
14a
Me Me PO(OEt)2
CuI
Toluene
NR
4
a
only the decomposition of starting material and dimerization observed
The methyl-protected chromene was then used to attempt the cyclopropanation
with diazo derivative 19b, which would produce the α-phosphono lactone 13 directly. A
different protocol was used for this, since it was already demonstrated in our lab that
cyclopropanation of 2-aryl-2H-chromenes using compound 19b under such conditions
were unsuccessful.10 A protocol used by Igor and co-workers for the cyclopropanation
using highly electron withdrawing diazo derivatives was then applied to our chromene.12
In this protocol chromene 15a and the diazo derivative 19b were refluxed in toluene in
the presence of CuI as a catalyst (Table 2.5, entry 4). Unfortunately, no indication of
product was observed as only the starting materials (14d and 19b) were recovered from
the reaction.
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Typically in cyclopropanation reactions the observance of dimerized product in
contrast to cyclopropane formation is a clear indication that the carbene/carbenoid
species, which is necessary for the reaction to occur, is being generated. The dimerized
product was not observed in this reaction; therefore it is safe to suggest that this reaction
condition failed due to the inability of the CuI catalyst to generate the pivotal carbenoid
species, resulting in the lack of cyclopropanated product. This route to the α-phosphono
lactone was therefore abandoned and the longer route was pursued.
Cyclopropane 14d was then treated with Sn(OTf)2 which resulted in the
rearrangement of the cyclopropane into γ-lactone 20 in a 78 % yield (Scheme 2.3). This
rearranged product maintains the anti- stereochemistry as the preceding cyclopropane,
which has been confirmed in our lab by means of an X-ray crystal structure.13

Rearrangement of cyclopropane to γ-lactone.

With this rearranged product in hand several attempts were then made to
synthesize lactone 21 (Table 2.6). Initially, it was thought to use conventional methods
of refluxing in the presence of aqueous acid to effect this transformation. However, after
careful consideration this route was not pursued, due to the lability of the chomanframework, as well as the lactone moiety, to acidic conditions. Basic conditions for the
decarboxylation reaction were then attempted, but unfortunately this proved futile (Table
20

2.6, entry 1). Therefore, Krapcho’s method for the dealkoxycarbonylation of esters with
α-electron withdrawing substituents was implemented (Table 2.6, entries 2-5).14-15 This
protocol occurs under relatively mild conditions and thus can tolerate a wide array of
functional groups and protective groups. Refluxing a solution of the lactone 20 in
anhydrous DMF, in the presence of sodium iodide, proved to be the most successful of
these methods; yielding the desired product in a 91 % yield (Table 2.6, entry 5).
Decarboxylation of lactone

Entry
Conditions
1. 1 M KOH. MeOH, overnight
1
2. Toluene reflux 2hrs
NaCl, wet DMSO, reflux 2hrs
2
NaCl, Dry DMSO heat 1.5 hrs
3
NaCl, wet DMF reflux 2hrs
4
NaI, DMF reflux 5hrs
5
a
decomposition of starting material

% Yield
---a
50
76
---a
91

With lactone 21 in hand, attempts were made for the synthesis of the αphosphono lactone, using a protocol developed by Wiemer and coworkers.16 This method
was selected in preference to the alternate choice of the classical Arbuzov reaction for
two main reasons: 1) use of the Arbuzov’s protocol would require the formation of an αbromo lactone, which may be problematic and 2) even if the bromination was successful,
phosphonation would necessitate a SN2 reaction which may again be problematic owing
to the sterically hindered lactone. Wiemer’s protocol allows for the direct synthesis of
the α-phosphono lactone from lactone 21 via the formation of an enolate.
21

Initial attempts at synthesizing the phosphono lactone using this protocol began
with the use of diethyl chlorophosphate as the phosphorylating agent (Scheme 2.4). In
this protocol the lactone was treated with LDA followed by the phosphorylating agent to
generate vinyl phosphate 22.17 This vinyl phosphate was then treated with LDA, which
promotes the rearrangement of the vinyl phosphate to the required α- phosphono lactone
23. To much dismay, this attempt was did not produce compound 23.

Diethyl chlorophosphate approach to α- phosphono lactone

Another protocol developed by the same group, which employs the use of diethyl
chlorophosphite as the phosphorylating agent, was then pursued.18 The results obtained
for this protocol are summarized in Table 2.7. Following the unmodified literature
procedure, the lactone 21 was first treated with LDA followed by diethyl chlorophosphite
(entry 1), yielding the desired product as a mixture of diastereomers, in a meager 24.2 %
yield. It was then thought to implement additives in an attempt to improve the reaction
yield. As is evident in entries 2 and 3, the use of the additives, HMPA and TMEDA
22

respectively, did improve the yield. LHMDS was then employed as a base, to see whether
changing the base would also improve the yield. In fact, when LHMDS was used in the
presence of TMEDA, the yield obtained was the highest of all reactions attempted (entry
5). This yield was comparative to literature examples of sterically hindered lactones, thus
no further optimizations were done for this reaction.
Phosphonation of lactone using diethyl chlorophosphite

Entry
Base
Additive % Yield
LDA
none
24.2
1
LDA
HMPA
31
2
LDA
TMEDA
34
3
LHMDS
none
24
4
LHMDS TMEDA
43
5
a
air oxidation: reaction flask was left opening to the atmosphere stirring overnight
Synthesis of α-benzylidene lactones 24
With the α-phosphono lactone 23 in hand, attempts were made to synthesize the E
and Z isomer of the key intermediate, α-methylene lactone 24 (Figure 2.1). Initial
attempts to synthesize this lactone began with an employment of a HWE olefination
approach by treatment of the α-phosphono lactone with an aldehyde in the presence of
base (section 2.3.1). Since this synthetic route did not yield the desired product, an aldol
reaction approach had to be implemented (section 2.3.2).
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Key intermediate, α-benzylidene lactone to be synthesized

HWE approach to α-benzylidene lactone
Initial conditions applied for HWE olefination were implemented to
stereoselectively generate the E and Z isomer of the α-benzylidene lactone. In this
protocol, the α-phosphono lactone was treated with KHMDS, followed by treatment with
18-crown-6-ether and p-anisaldehdye. The stereochemical outcome of the reaction is
dependent on how quickly the reaction is warmed to room temperature following the
addition of the reagents (Scheme 2.5). It has been demonstrated that application of the
HWE reaction using these reaction conditions on α-phosphono lactones followed by slow
warming leads exclusively to the E-isomer, while fast warming leads to the Z-isomer.19

HWE approach to α-benzylidene lactone

Unfortunately, application of this protocol to our phosphono lactone, resulted in
only α-phosphono lactone 23 being recovered (Table2.8, entries 1 & 2). Alternate bases,
24

which are typically employed in HWE olefinations, were then employed. Regrettably,
these methods were also unsuccessful (Table 2.8, entries 3 & 4).
Horner Emmons Olefination of phosponate ester

Entry
Conditions
1. KHMDS,18C6E -78oC
1
2. RCHO -78oC
3. Slow waminga to RT

Yield
NR

2

1. KHMDS, 18C6E -78oC
2. RCHO -78oC
3. Fast wamingb to RT

NR

3

NaH, THF, reflux

NR

K2CO3, reflux
NR
4
o
Slow warming: reaction was started at -78 C in a covered dewar flask. After the
addition of the aldehyde the covering of the flask was removed and the reaction was
allowed to slowly come to room temperature. b Fast warming: after the addition of the
aldehyde the reaction flask was immediately removed from the dewar flask and placed in
a water bath at 30 oC.
a

With unsuccessful application of the HWE olefination conditions to our lactone
23, it was then concluded that lack of production of the desired product could be
attributed to no formation of the required enolate. The α-phosphono lactone was therefore
treated with KHMDS, followed by treatment with 18-crown-6-ether and MeI. Successful
methylation of the α-phosphono lactone would be a strong indicator that the enolate is
being generated under these reaction conditions. Indeed the methylation was successful,
albeit in a low 43 % yield (Scheme 2.6). This proved that the enolate was indeed
25

generated under these conditions, thus the failed reactivity with p-anisaldehyde, a much
bigger electrophile than MeI, could be attributed to steric hindrance.

Methylation of α-phosphono lactone

Aldol approach to enone
Since the HWE reaction was unsuccessful, an alternate strategy towards the
synthesis of α- benzylidene lactone 24 was taken. In this approach an aldol condensation
methodology would be pursued. If the aldol condensation reaction does not yield the
required α-benzylidene lactone (route 1); an indirect approach (route 2) could be taken,
where the aldol product would be first generated and subsequent mesylation and
elimination would fabricate the desired product (Scheme 2.7).

Aldol approach to α-benzylidene lactone

26

For direct α-benzylidene lactone synthesis, standard conditions for aldol
condensation reactions were applied. Treatment of a solution of lactone 21 and panisaldehyde with 60 % KOH in ethanol and stirring overnight, resulted in no formation
of the desired product (Scheme 2.8). Lactone 21 was consumed in the reaction, however
only p-methoxybenzoic acid and p-anisaldehyde were recovered from the reaction. Since
this direct route was futile, the viability of route 2 was then investigated.

Aldol condensation synthesis of α- benzylidene lactone

In pursuit of the second route, several reaction conditions were applied for the
formation of aldol product 26 (Table 2.9). Initial conditions that were applied were
geared towards the diastereoselective synthesis of 26. Lactone 21 was therefore treated
with dibutyl boron triflate in the presence of Hünig’s base at -78 oC, followed by the
addition of p -anisaldehyde. This Mukaiyama aldol reaction has been shown to yield a
single diastereomer when applied to lactones.20 Upon warming the reaction to room
temperature after stirring at 0 oC for 2 hours, as described in the literature, no formation
of product was observed (Table 2.9, entry 1). The reaction was repeated under the same
conditions but was quenched at -78 oC instead. This change in reaction conditions
resulted in the isolation of the product in an 8.3 % yield as a single diastereomer (Table
2.9, entry 2).
27

The lactone was then treated with LHMDS and then p- anisaldehyde to produce
26. Warming the reaction to room temperature after the addition of p-anisaldehyde
resulted in an improved yield of 25 % (Table 2.9, entry 3). The reaction was repeated but
was quenched at -78 oC instead. To much delight, this resulted in the isolation of the aldol
product in a 76 % yield as an inseparable mixture of diastereomers (Table 2.9, entry 4).
KHMDS was also applied to see if this would have resulted in a higher yield, however a
much lower yield was obtained (Table 2.9, entry 6).
Conditions employed in the synthesis of aldol 26

Entry
1

Conditions
% Yield
1. Bu2 BOTf, DIPEA -78 oC to RT
---a
2. RCHO 0oC to RT

2

1. Bu2 BOTf, DIPEA -78 oC
2. RCHO -78oC; quench at -78 oC

8.3b

3

1. LHMDS -78oC
2. RCHO ; -78oC to RT

25

4

1. LHMDS -78oC
2. RCHO -78oC; quench at -78 oC

76

5

1. LHMDS -78oC
2. Bu2 BOTf, DIPEA -78 oC
3. RCHO; quench at -78 oC

14b

1. KHMDS -78oC
2. RCHO -78oC; quench at -78 oC
a
decomposition of starting material; bsingle diastereomer isolated
6

28

26

Aldol product 26 was then converted to α-benzylidene lactone 24 in a one pot
two-step sequence. Aldol product 26 was first mesylated by treatment with
methanesulfonyl chloride and triethylamine. This was followed by elimination of the
nascent mesylate by treatment with a base. When the mesylate of 26 was treated with
potassium tert-butoxide, the desired product was isolated in a 62 % yield in an E/Z ratio
of 5:2 (Table 2.10, entry 1). DBU was the next base used for the elimination of the
mesylate, since Kang and coworkers, in a protocol to generate α-benzylidene lactones
from the aldol product of γ- lactones, demonstrated the exclusive formation of the Eisomer in several cases.21 Treatment of our mesylate with DBU, while it did not lead to
the exclusive formation of the E-isomer, significantly improved the yield to 82 %, with
an E/Z ratio of 3:2 (Table 2.10, entry 2).
Synthesis of α-benzylidene lactone

a

determined by NMR

Entry Base % Yield E/Z ratioa
KOtBu
62
5:2
1
DBU
82
3:2
2

The ratio of E/Z-isomers was determined from the integration of the vinyl proton.
The vinyl proton for the E-isomer occurs as a singlet at δ = 7.53 ppm, while the
corresponding signal of the Z-isomer occurs more upfield at δ = 5.89 ppm (Figure 2.2).
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Chemical shift differences between E and Z α-methylene lactone 24a

This mixture of stereoisomers was difficult to separate via conventional flash
column chromatography, even when using different solvent systems such as;
hexane/EtOAc, hexane/Et2O and DCM/MeOH. Efforts made to separate them by using a
silver impregnate silica column were also unsuccessful. As a result, the olefin product
was carried to subsequent steps of the synthesis as a mixture, with the anticipation that a
successful separation would be feasible at a later stage in the synthesis.
Lactone ring opening
With the α-benzylidene lactone in hand, attention was turned towards the
synthesis of the chalcone precursor 27 (Figure 2.3). Lactone ring opening via a lithiation
reaction proved to be more difficult than anticipated. As a result several different
approaches had to be employed towards the synthesis of the chalcone precusor.

a

Spectra for pure isomers were obtained by collection of the 1st and last fraction
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Targeted chalcone precursor to biflavonoids

Direct approach: Reaction of lactone with aryllithium 12
In the initial attempt made to synthesize the chalcone precursor, α-benzylidene
lactone 24 was treated with known22 aryllithium 12 at -78 oC (Scheme 2.9).
Unfortunately, only starting material was recovered from the reaction. Presumably the
lack of reactivity could be attributed to the sterically hindered α-benzylidene lactone
being unsusceptible to attack by a large nucleophile, as is the case of the aryl lithium
used.

Attempted approach to chalcone precursor

Weinreb amide approach
Since the direct approach to the acylation was did not yield the desired product, a
Weinreb amide approach was then attempted (Scheme 2.10). In this approach the αbenzylidene lactone 24 would be treated with HNMe(OMe) in the presence of a Lewis
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acid to give Weinreb amide 30. Generation of Weinreb amides from similar αbenzylidene lactones has been previously accomplished by the treatment of αbenzylidene lactones with an amine in the presence of AlMe3.23 This Weinreb amide can
then be treated with aryllithium 12 followed by oxidation to give chalcone 29.

Proposed Weinreb amide approach

In order to synthesize Weinreb amide 30 standard conditions were initially
applied: α-methylene lactone 24 was treated with N, O-dimethylhydroxylamine in the
presence of trimethylaluminium as the Lewis acid (Table 2.11, entry 1). Unfortunately,
the desired product was not observed. After a survey of the literature, other methods were
attempted. These methods present a slight modification to the Weinreb methodology, and
have been shown to significantly improve the yield of Weinreb amides derived from
lactones. 24-25 Unfortunately, application of these methods to our lactone also proved
futile in yielding the desired product (Table 2.9 entries, 2 & 3).
Conditions employed in the synthesis of Weinreb amide 30.
ENTRY Conditions Yield
AlMe3
NR
1
AlMe2Cl
NR
2
Dibal-H
NR
3
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With the unsuccesful attempts at opening the α-benzylidene lactone via the direct
lithiation approach and the Weinreb amide approach, it was concluded that sterics may
have played a role in the lack of formation of the desired product. That is, the sterically
hindered α-benzylidene lactone was not susceptible to attack by large nucleophiles. As a
result, it was thought that use of a much smaller nucleophile might achieve the ring
opening. Therefore, the next reactions that were attempted involved the α-benzylidene
lactone ring opening via basic and acidic conditions.
Base/ acid catalyzed opening of the lactone 24
In this approach basic or acidic conditions would be used to initiate the lactone
ring opening into either the ester or acid, dependent on conditions used (Scheme 2.11).
The ester or the acid produced by lactone ring opening could be converted into a Weinreb
amide and then reacted with the aryllithium to produce the desired chalcone precursor 29.
Alternately, this could be achieved in one-pot. The one-pot conversion of either acids or
esters directly to ketones via the in situ generation of Wienreb amides has been reported
in literature.26-28

Proposed base/ acid catalyzed approach to chalcone 29
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Several different bases were employed to attempt the base catalyzed lactone ring
opening (Table 2.12). Unfortunately, all conditions attempted were unfruitful. When
using lithium hydroxide as the base, it was noticed while tracking the reaction by TLC
that the starting material was consumed prior to work-up and purification by flash
column chromatography. However, when the reaction was worked-up and purified, only
starting material was recovered, indicating the product had converted back into the
starting material upon work-up. This may be due to the facile recyclization of the
hydroxy acid produced by the base catalyzed ring opening. γ-Lactones are known to have
a high rate of ring closure due to their relatively low activation energy.29 Furthermore,
this observation could possibly be explained by the Thorpe – Ingold effect, where it is
known that the presence of quaternary carbons in an alkyl chain tends to increase the rate
of cyclization.30
In light of this facile recyclization, attempts were made to afford the formation of
the hydroxyl-acid by utilizing an alkoxide, such as sodium methoxide (Table 2.12, entry
4 & 5) or sodium ethoxide (Table 2.12, entry 5), in the opening of the lactone.
Unfortunately, these attempts were also unfruitful. It has been demonstrated that
treatment of the crude hydroxyl-acid with a methylating reagent, such as methyl iodide or
dimethylsulfate, has prevented the unwanted recyclization.31,32 Application of these
conditions to our lactone were also unsuccessful (Table 2.12, entries 7 & 8).
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Conditions applied for the basic/ acidic lactone ring opening

ENTRY
1
2
3
4
5
6
7
8

Conditions
Et3N, MeOH
NaOH, MeOH
LiOH, MeOH
MeONa, MeOH
MeONa, THF
EtONa, EtOH
1. LiOH, MeOH
2. MeI, DMF

1. LiOH, THF
2. Me2SO4, DMSO

H2SO4, H2O/ THF
9
a
Starting material was recovered upon work-up

Yield
---a
---a
---a
---a
---a
---a
---a
---a
---a

Reduction of lactone approach to chalcone precursor
Since the acidic/basic approach did not yield the desired product, an alternate
approach was embarked upon (Scheme 2.12). This approach involved reduction of the αbenzylidene lactone to diol 32, followed by oxidation to 33. Treatment of keto-aldehyde
33 with the aryllithium followed by oxidation should give the target chalcone 29. It is
anticipated that the greater reactivity of the aldehyde versus the less reactive and more
sterically hindered ketone, should ensure exclusive addition of the aryllithium to the
aldehyde and not the ketone, with the use of one equivalent of the aryllithium.
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Reduction approach to chalcone 29

Lithium aluminum hydride (LAH) was used In the initial attempt of the reduction
of the α-benzylidene lactone. However, the reaction never went to completion, even when
the reaction was stirred for 2 days in the presence of a large excess of LAH. The reducing
agent was then changed to Red-Al, which yielded diol 32 in an 83 % yield (Scheme
2.13). Fortuitously at this stage of the synthesis the E and Z isomers were separable by
conventional flash column chromatography.

Reduction of α-benzylidene lactone to diol

With diol 32 in hand, oxidation to the keto-aldehyde 33 was attempted. Initially, it
was thought that concurrent oxidation of the alcohols present in the diol 32 would be the
best course of action since asynchronous oxidation may lead to the oxidation of the
primary alcohol first. This may then be followed by undesired intramolecular cyclization
of the secondary alcohol onto the nascent aldehyde, forming a hemiacetal 34, which can
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be further oxidized to α-benzylidene lactone 24 (Scheme 2.14). Thus, the diol was treated
with two equivalents of the respective oxidizing agent, with the exception of the
application of MnO2, which typically requires a much larger fold excess (10 – 20 eq) of
the oxidant for successful oxidation.

Intramolecular cyclization caused by asynchronous oxidation

Initially, well-known conditions for concurrent oxidations were applied (Table
2.13, entries 1 & 2). Applications of these conditions, PCC and Swern oxidative
conditions, resulted in the decomposition of the diol. MnO2 was then applied for the
oxidation, since it has been known to oxidize both allylic and benzylic alcohols (Table
2.13, entry 3). Unfortunately, when diol 32a was treated with MnO2, only α-benzylidene
lactone 24 was obtained in a 51 % yield (Table 2.13, entry 3).
IBX, another reagent commonly used for the oxidation of benzylic and allylic
alcohols, was then applied. In that case, no reaction occurred as only diol 32a was
recovered from the reaction (Table 2.13, entry 4). With the use of DDQ the desired ketoaldehyde was not obtained. However, hydroxy-aldehyde 36 was obtained, albeit in a low
32 % yield (Table 2.13, entry 5). It should be noted that the intramolecular cyclization to
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hemiacetal 35 followed by the oxidation could not be avoided, even with the use of one
equivalent of DDQ; as the α-benzylidene lactone 24 was also isolated in a 28 % yield.
Oxidative conditions for synthesis of intermediate 7.

% Yield
Entry Conditions 33
36
24
a
b
PCC
N.O N.O N.O
1
a
Swern
N.O N.O N.O
2
MnO2
N.O N.O 51
3
IBX
N.O N.O N.O
4
DDQ
N.O 32
28
5
a
b
decomposition of starting material N.O = not observed
Protection/deprotection approach to keto–aldehyde 33
Alas, the direct approach to keto-aldehyde 33 was not as successful as anticipated,
thus a protection/deprotection strategy had to be utilized (Scheme 2.15). Firstly, it was
thought to selectively protect the allylic alcohol of the diol as a triethyl silyl (TES) group.
The TES group was selected as the protective group of choice since it has been
demonstrated that it can be converted directly to an aldehyde or a ketone by the
application of Swern oxidation conditions. Once the allylic alcohol is protected, the
benzylic alcohol can then be oxidized. Deprotection and oxidation should yield the
desired keto-aldehyde. The keto- aldehyde can then be treated with the respective
aryllithium followed by oxidation to yield the required chalcone.
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Protection /deprotection approach to chalcone precursor

Selective protection33 of the allylic alcohol of diol 32a, was achieved by the
addition of 2,6-lutidine and TESCl to a solution of the diol in DCM , yielding mono
(TES) ether 37a in an 80 % yield (Scheme 2.16).

Selective TES protection of allylic alcohol of diol

With successful selective protection of the allylic alcohol, several conditions were
then attempted for the oxidation of the benzylic alcohol. These results have been
summarized in Table 2.14. Application of IBX and manganese dioxide, resulted in no
observable reaction as only compound 37a was recovered from the reaction.
Auspiciously, when Dess-Martin periodinane (DMP) was used for the oxidation, the
desired ketone 38a was obtained in a 77 % yield.
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Oxidative conditions applied for oxidation of benzylic alcohol in 37a.

Entry Oxidant % Yield
MnO2
NR
1
Swern
---a
2
IBX
NR
3
DMP
77
4
adecomposition
For the deprotection of the TES ether, DDQ was implemented, which has been
shown to have the ability of converting electron-rich silyl ethers directly into aldehydes.34
Thus a solution of ketone 38a at 0 oC was treated with DDQ (Scheme 2.17) and then
warmed to room temperature. The desired keto-aldehyde was isolated in a 78 % yield.

Synthesis of keto-aldehyde

With keto-aldehyde 33a in hand, the lithiation reaction was attempted. The
aryllithium to be used for this lithiation was first prepared by the protection of 3,5dimethoxyphenol as a MOM ether under standard conditions. The MOM ether was then
treated with tert- butyllithium at -78 oC which produced ortho-lithiated MOM ether
12.22
40

The freshly prepared aryllithium was then titrated into the solution of the ketoaldehyde 33a in toluene at -78 oC and monitored by TLC. Maintaining the temperature at
-78 oC, resulted in no product formation. The reaction mixture was then slowly warmed
to room temperature which resulted in multiple spots appearing on TLC. Upon work-up
and purification the desired lithiated product 39a was isolated in a disappointing 16 %
yield (Scheme 2.18).

Lithiation of Keto- aldehyde 33a

Bis (TES) Ether protected diol approach to chalcone precursor
With such a low yield obtained with the keto-aldehyde, it was then thought to
alter the protocol to ensure that only one carbonyl moiety was present (the aldehyde).
Thus the diol 32a was treated with DMAP, imidazole and TESCl, which yielded bis
(TES) ether 40a in a 75 % yield (Scheme 2.19).

Bis (TES) ether synthesis
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With the bis (TES) ether in hand attempts were then made to selectively remove
the allylic TES ether. These results have been summarized in Table 2.15. Swern oxidative
conditions have been shown to convert allylic TES directly to a carbonyl group in the
presence of other TES ethers, 35 therefore this was the first method used to attempt this
transformation. Implementation of Swern conditions for this selective
deprotection/oxidation resulted in multiple spots being observed on TLC (Table 2.15,
entry 1). Only one of these isolated spots showed trace presence of the aldehyde by NMR
analysis, with a characteristic chemical shift at 9.6 ppm. This method was therefore
abandoned and an alternate protocol was sought.
A survey of the literature found that DDQ34 has also been used to convert TES
ethers directly to the carbonyl group. Thus, bis (TES) ether 40a was treated with DDQ at
0 oC. The mixture was then warmed to room temperature and monitored for completion.
After stirring for 7 hours at room temperature the starting material was still present;
therefore an additional 1 equivalent of DDQ was added and the reaction was stirred for a
further 2 hours. This resulted in aldehyde 41a being isolated in a 42 % yield. However, αbenzylidene lactone 24a was also isolated in a 31 % yield (Table 2.15, entry 2).
The α-benzylidene lactone formation resulted from the use of excess DDQ.
Addition of the 1st equivalent was successful in oxidizing the allylic TES ether to
aldehyde 41a, while addition of the 2nd equivalent resulted in deprotection of the benzylic
TES ether, followed by intramolecular cyclization onto the nascent aldehyde and the
oxidation to give the α-benzylidene lactone (see Scheme 2.14).
The reaction was then repeated using just 1 equivalent of DDQ; after stirring for 7
hours at room temperature starting material was still present, thus the reaction was left to
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stir overnight. This resulted in complete decomposition of the starting material as well as
the desired product that was formed, indicating that the reaction time was too long (Table
2.15, entry 3).
The reaction was then repeated, and the reaction was quenched at the 7 hour
mark, in spite of the fact that starting material was still present. In this case the desired
product was isolated in a 62 % yield; a 79 % yield when the recovered starting material is
taken into consideration (Table 2.15, entry 4). Even with the use of 1 equivalent DDQ the
side product formed from this reaction, α-benzylidene lactone 24, could not be avoided,
as it was also isolated in a 7.4 % yield.
Oxidative conditions applied to compound 40a

ENTRY OXIDANT EQ REACTION TIME % YIELD
(COCl)2
1
2 hrs
---a
1
DDQ
2
7 hrs
42 (31)b
2
DDQ
1
16 hrs
---c
3
DDQ
1
7 hrs
62(79)c
4
a
trace; b yield of α-benzylidene lactone 24; c decomposition; d yield based on recovered
40a
Applying these same conditions for sequential deprotection and oxidation to the
aldehyde for the Z-isomer 40b resulted in no formation the desired product. As a result, a
two–step protocol had to be applied to Z-bis (TES) ether 40b for the synthesis of Zaldehyde 41b (Scheme 2.20). In this protocol the primary TES group 40b was selectively
cleaved36 by treatment with K2CO3 in MeOH, which furnished primary alcohol 42 in a 69
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% yield. Subsequent treatment of 42 with MnO2 produced the desired aldehyde 41b in a
68 % yield. Application of TEMPO/BAIB, for the oxidation of the allylic alcohol,
increased the yield to 75 %.

Strategy implemented for the synthesis of Z-aldehyde 41b

The lithiation reaction was then attempted with aldehyde 41a which successfully
yielded the desired product as a mixture of epimers in a 71 % yield (Scheme 2.21). The
complications seen with the lithiation reaction utilizing keto-aldehyde 33a were not
observed (section 2.4.4.1).

Lithiation of aldehyde 41a
44

Disenchantingly, application of these reaction conditions to the Z-isomer resulted
in no formation of the desired product as only aldehyde 41b was recovered from the
reaction (Scheme 2.22). Failure of the lithiation reaction may be attributed to steric
crowding of Z-aldehyde 41b, which in turn prevents attack of the aldehyde by the bulky
lithiating reagent 12.

Lithiation of z-aldehyde 41b

With alcohol 42a in hand, attempts were made to synthesize chalcone 43a via the
oxidation of the allylic alcohol (Scheme 2.23). Unfortunately, all conditions applied to
achieve this were futile. Use of MnO2 resulted only in the recovery of alcohol 42a, even
when 20–30 equivalents of the oxidant was used and the reaction was stirred for 3 days.
Implementation of DDQ or DMP, resulted in the elimination of the TES protective group,
yielding chromene 44 (Scheme 2.23) as the major product of the reaction. In the case of
use of DMP, the desired chalcone 43a was also obtained in a 26 % yield.
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Oxidative conditions applied for the synthesis of chalcone 43

With the possibility of the elimination of the TES protective group in mind, it was
then thought that a better route would be to first deprotect the TES group, then
concurrently oxidize both of the alcohols present in the diol produced (Scheme 2.24).
Therefore, allylic alcohol 42a was treated with TBAF, which gave diol 45 in an 83 %
yield.
Concomitant oxidation of both the benzylic and allylic alcohols was then
attempted. This oxidation was not straightforward: use of MnO2 resulted in no reaction;
when DMP was used, even though 2 equivalents were used, only one of the alcohols in
diol 45 was oxidized (26 % yield); application of DDQ resulted in a mixture of the monooxidated and bis-oxidated product (~ 43 % yield of inseparable mixture). b Swern
oxidative conditions were also applied, but this resulted in decomposition of the diol.
Sequential oxidation of the diol, by 1st using DMP and then DDQ or vice versa, also
proved futile.
Difficulties with the concomitant oxidation of both alcohols in diols have been
reported in literature. In one such case the oxidation was achieved by sequential treatment

b

Product formed was confirmed by HRMS
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of the diol with DMP and then Jones’ reagent.37 In our case the use of such a strongly
acidic reagent (Jones’ reagent) is not applicable.

Synthesis of chalcone precursor

The deprotection of the MOM group was then attempted using the inseparable
mixture of the mono/bis-oxidated product. Unfortunately, attempts made to remove the
MOM group using standard condition for MOM deprotection (p-toluenesulfonic acid in
MeOH and HCl in methanol), resulted in the decomposition of the starting material.
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CONCLUSION & FUTURE PERSPECTIVES

In this study a synthetic route towards the synthesis of chamaejasmine and
isochamaejasmine, each containing four stereogenic centers, has been developed. The
strategy applied for this synthesis has been depicted in Scheme 3.1. The goals of this
dissertation were as follows:
I:

Install stereocenters at C-2 and C-3

II:

Synthesize E/Z chalcone precursors to the biflavonoids

III:

Test the hypothesis that E/Z chalcones cyclize with complete trans
selectivity and yield trans products with opposing stereochemistry.

Goal I was achieved through the cyclopropanation of chromene 15c followed by
rearrangment into γ-lactone 20. This created the framework for one of the flavanone units
in these biflavonoids, in addition to the building block to the 2nd flavanone unit. In order to
accomplish goal II, γ-lactone 20 was transformed into aldol product 26. Aldol product 26
was then converted into α-benzylidene lactone 24. This conversion produced the desired
E/Z configuration for the chalcone precursor. Lactone ring opening, formation of an
aldehyde, followed by addition of aryllithium 12 and oxidation furnished the desired Echalcone precursor 29. Efforts made to synthesize the Z-chalcone precursor using the same
strategy were futile.
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Overall strategy to the synthesis of chalcone precursor 29

The oxidation reaction to yield E-chalcone precursor 29 from a diol was a
challenge and only furnished the desired chalcone in less than 43 % yield as a mixture of
the desired product, as well as the mono oxidized product. Therefore, an alternate strategy
needs to be implemented in order to obtain the chalcone precursor in an improved yield.
One such approach would involve revisiting the keto-aldehyde strategy discussed
in section 2.4.4.1. In this strategy, the addition of the aryllithium to the aldehyde only
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yielded the desired product in a 16 % yield, due to the multiple side reactions. This yield
may be improved through the use of alternate reagents instead of the very reactive
aryllithium. Less reactive reagents such as Grignard, Gilman and organozinc reagents may
be implemented for the addition (Scheme 3.2). These methods would ensure the need to
oxidize only one alcohol to produce the desired chalcone precursor, thereby eliminating
the issue of the mixture of products obtained when oxidizing the diol.

Alternate strategy to chalcone precursor

Another issue which arose from the protocol used to form the chalcone precursor
was the deprotection of the MOM group in compound 29. Attempts made to deprotect the
MOM group resulted in the decomposition of 29. As a result of this goal III in this study
was not accomplished.
Utilizing the alternate strategy proposed above (Figure 3.2) goal III could be
accomplished by allowing the protective group (R) used in arylating reagent 45 to be
varied. As a result, protective groups other than MOM that could be removed under milder
conditions (non-acidic conditions) can be implemented in the arylating reagent 45 used in
the addition to the aldehyde 33a. Research is ongoing to test the viability of this route in
synthesizing the desired chalcone precursor in a decent yield.
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EXPERIMENTAL PROCEDURES

General experimental methods
All reactions were performed using oven-dried glassware under inert atmosphere
(Ar or N2). Reactions were monitored by TLC using Sorbent Technology silica gel TLC
plates (UV 254) and PMA, KMnO4 or DNP for visualization. Column chromatography
was performed on silica gel using mixtures of hexane and EtOAc as the eluting solvents
unless otherwise noted. Flash purification of compounds was conducted using BiotageIsoleraTM One. Anhydrous DMSO, DMF, and toluene were purchased from Sigma
Aldrich in a SureSealTM bottle and used without further purification. Other solvents and
reagents (such as THF, DCM, Et3N, and acetonitrile) were dried over sodium
benzophenone ketyl or calcium hydride and distilled before use. The 1H NMR and 13C
NMR spectra were recorded on a Bruker-Avance 300 or 600 MHz instrument in CDCl3
and data are reported as chemical shift (δ) in ppm from tetramethylsilane as an internal
standard. For 13C NMR spectra data are reported as δ in ppm from tetramethylsilane with
the solvent as an internal indicator (CDCl3, 77.16 ppm). Samples of new compounds
were submitted to Mississippi State University for HRMS analysis. Melting points were
determined with a Barnstead International MEL-TEMP melting point apparatus and are
uncorrected. Note: Compounds that have been previously characterized have citations
after their chemical name.
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Synthesis of diprotected acetophenones

Synthesis of 1-(2,4-bis(benzyloxy)-6-hydroxyphenyl)ethanone (17a)1

To a solution of 2,4,6-trihydroxyacetophenone (1.05 g, 5.680 mmol) in HMPA (7
mL) was added potassium carbonate (2.24 g, 16.08 mmol) and benzyl chloride (1.36 mL,
10.80 mmol). The resulting suspension was stirred under reflux overnight. The reaction
mixture was then poured into ice water and acidified to pH 2 with 6 M HCl. The mixture
was then extracted with EtOAc (x 3) and the combined organic layers were washed with
brine and dried over Na2SO4. The solvent was removed under reduced pressure and the
residue was purified by flash column chromatography. Yield: 1.4 g, 71 %; clear oil; 1H
NMR (600 MHz, CDCl3): 14.00 (s, 1H), 7.43-7.34 (m, 10H), 6.15 (d, J = 2.3 Hz, 1H),
6.10 (d, J = 2.3 Hz, 1H), 5.06 (s, 2H), 5.05 (s, 2H), 2.57 (s, 3H)

Synthesis of 1-(2-hydroxy-4,6-bis(methoxymethoxy)phenyl)ethanone
(17b)2

To a solution of 2,4,6-trihydroxyacetophenone (500 mg, 2.680 mmol) in DCM (6
mL) at 0 oC was slowly added DIPEA (1.32 mL, 7.580 mmol). The reaction mixture was
stirred for 20 minutes before chloromethyl methyl ether (0.48 mL, 6.32 mmol) was added
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dropwise. After stirring at room temperature for 2 hours the reaction mixture was
quenched with deionized water and the aqueous layer was extracted with DCM (3x, 10
mL). The combined organic layers were then washed with brine and dried over
anhydrous Na2SO4. The solvent was removed under reduced pressure and the residue
purified by flash column chromatography. Yield: 482 mg, 70 %; clear oil; 1H NMR (300
MHz, CDCl3): δ 13.74 (s, 1H), 6.23 (s, 2H), 5.26 (s, 2H), 5.16 (s, 2H), 3.52 (s, 3H), 3.46
(s, 3H), 2.63 (s, 3H).

Synthesis of 1-(2-hydroxy-4,6-dimethoxyphenyl)ethanone (17c)3

To a solution of 2,4,6-trihydroxyacetophenone (10.11 g, 54.2 mmol) in dry
acetone (214 mL) was added K2CO3 (14.98 g, 107.8 mmol) and dimethylsulfate (10.3
mL, 108.4 mmol). The reaction was refluxed for 5 hours, after which it was cooled to
room temperature and poured into ice water (200 mL). The resulting white precipitate
was filtered and washed with cold water. Yield: 9.25 g, 87 %; white solid; 1H NMR (300
MHz, CDCl3): δ 14.02 (s, 1H), 6.06 (d, J = 2.21 Hz, 1H), 5.93 (d, J = 2.21 Hz, 1H), 3.85
(s, 3H), 3.82 (s, 3H), 2.61 (s, 3H).
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Synthesis of 2′- hydroxychalcones
Procedure A
To a solution of the 2′-hydroxyacetophenone (1.4 g, 4.04 mmol) and panisaldehyde (0.939 g, 4.42 mmol) in anhydrous DMF (20 mL) at 0 oC was added NaH
(397 mg, 16.54 mmol). The resulting solution was warmed to room temperature and
stirred overnight. The reaction mixture was diluted with H2O and extracted with EtOAc
(3x, 20 mL). The combined organic layers were washed with brine and dried over
anhydrous Na2SO4. The solvent was removed under reduced pressure leaving a solid
residue, which was recrystallized from 100% MeOH.
Procedure B
To a solution of 2′ - hydroxyacetophenone (1.00 g, 5.09 mmol) and panisaldehyde (0.62 mL, 5.09 mmol) in ethanol (20 mL) was added a solution of
potassium hydroxide (4 mL, 107 mmol, 60% w/w). After stirring at room temperature
overnight, the reaction was neutralized with saturated NH4Cl and extracted with EtOAc
(x3). The combined organic layers were washed with brine and dried over anhydrous
MgSO4 The solvent was removed under reduced pressure leaving a solid residue, which
was recrystallized from 100% MeOH.

Synthesis of (E)-3-(4-(benzyloxy)phenyl)-1-(2,4-bis(benzyloxy)-6hydroxyphenyl)prop-2-en-1-one (18a)4
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Synthesized via procedure A. Yield: 1.93 g, 88%; yellow solid; m.p. 133.7-136.0
°C; 1H NMR (600 MHz, CDCl3): δ 14.7 (s, 1H), 7.81-7.78 (d, J = 15.5 Hz, 1H), 7.717.68 (d, J = 15.5 Hz, 1H), 7.50-7.36 (m, 15H), 7.00-6.99 (d, J = 8.5 Hz, 2H), 6.78-6.77
(d, J = 8.4 Hz, 2H), 6.22 (s, 1H), 6.17 (s, 1H), 5.10 (s, 2H), 5.08 (s, 2H), 5.05 (s, 2H).

Synthesis of (E)-3-(4-(benzyloxy)phenyl)-1-(2-hydroxy-4,6bis(methoxymethoxy)phenyl)prop-2-en-1-one (18b)5

Synthesized by procedure A. Yield: 48 %; yellow solid; m.p. 103 oC – 105 oC. ;
1

H NMR (600 MHz, CDCl3): δ 13.94 (s, 1H),7.84 (d, J = 15.5 Hz, 1H), 7.80 (d, J = 15.6

Hz, 1H), 7.56 (d, J = 8.7 Hz, 2H), 7.44 (d, J = 7.1 Hz, 2H), 7.41 (d, J = 7.3 Hz, 2H), 7.36
(d, J = 7.2 Hz, 1H), 7.01 (d, J = 8.7 Hz, 2H), 6.32 (d, J = 2.3 Hz, 1H), 6.25 (d, J=2.3 Hz,
1H), 5.29 (s, 2H), 5.19 (s, 2H), 5.12(s, 2H), 3.53 (s, 3H) 3.48 (s, 3H).

Synthesis of (E)-1-(2-hydroxy-4, 6-dimethoxyphenyl)-3-(4methoxyphenyl)prop-2-en-1-one (18c)6

Synthesized by procedure B. Yield: 1.33 g, 83 %; yellow solid; m.p. 112 oC – 115
o

C. 1H NMR (300 MHz, CDCl3) δ 14.36 (s, 1H), 7.90 (d, J = 15.6 Hz, 1H), 7.80 (d, J =
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15.6 Hz, 1H), 7.52 (d, J = 8.0 Hz, 2H), 7.22 (d, J = 8.0 Hz, 2 H), 6.11 (d, J = 2.3 Hz, 1H),
5.97 (d, J = 2.3 Hz, 1H), 3.92 (s, 3H), 3.84 (s, 3H), 2.40 (s, 3H).
Synthesis of Chromenes

Synthesis of 5,7-bis(benzyloxy)-2-(4-(benzyloxy)phenyl)-2H-chromene
(15a)4

To a solution of chalcone (200 mg, 0.369 mmol) in DME (4 mL) was added
NaBH4 (14 mg, 0.423 mmol). The mixture was then stirred for 5 mins at 85 oC. After
cooling to room temperature the mixture was diluted with EtOAc and washed with brine
(x3). The organic layer was dried over anhydrous Na2SO4 and was filtered. A solution of
boron trifluoride ethyl etherate (50 µL, 0.4051 mmol) in DCM (200 µL) was added and
the resulting mixture was stirred for 30 minutes at room temperature. The solution was
washed with brine (x3) and dried over Na2SO4. The solvent was removed under reduced
pressure and the residue was purified by flash column chromatography on neutral
alumina. Yield: 100 mg, 55 %; clear oil; 1H NMR (300 MHz, CDCl3;) δ 7.40-7.32 (m, 18
H), 6.97 (d, J = 8.7 Hz, 2H), 6.89 (dd, J = 9.9, 1.4 Hz, 1H), 6.18 (d, J = 2.2 Hz, 1H), 6.12
(d, J = 2.1 Hz, 1H), 5.78 (dd, J = 3.4, 1.8 Hz, 1H), 5.61 (dd, J = 9.9, 3.5 Hz, 1H), 5.05 (s,
2H), 5.01 (s, 2H), 4.94 (s, 2H).
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Synthesis of 2-(4-(benzyloxy)phenyl)-5,7-bis(methoxymethoxy)-2Hchromene (15b)

To a solution of chalcone (180 mg, 0.399 mmol) in DME (4 mL) was added
NaBH4 (15.4 mg, 0.408 mmol). The mixture was stirred for 5 mins at 85 oC. After
cooling to room temperature the mixture was diluted with EtOAc and washed with brine
(x3). The organic layer was dried over anhydrous Na2SO4 and was filtered. A solution of
boron trifluoride ethyl etherate (50 µL, 0.4051 mmol) in DCM (200 µL) was added and
the resulting mixture was stirred for 30 minutes at room temperature. The solution was
washed with brine (x3) and dried over Na2SO4. The solvent was removed under reduced
pressure and the residue was purified by flash column chromatography on neutral
alumina. Yield: 20 mg, 12%; clear oil; 1H NMR (300 MHz, CDCl3) δ 7.42 (m, 7H), 6.98
(d, J = 8.7 Hz, 2H), 6.85 (dd, J =10.0, 1.3 Hz, 1H), 6.36 (d, J = 2.2 Hz, 1H), 6.24 (d, J =
2.1 Hz, 1H), 5.81-5.79 (m, 1H), 5.64 (dd, J = 10.0, 3.4 Hz, 1H), 5.18 (s, 2H), 5.10 (s,
2H), 5.08 (s, 1H,), 3.51 (s, 3H), 3.45 (s,3H).

Synthesis of 5,7-dimethoxy-2-(4-methoxyphenyl)-2H-chromene (15c)7
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To a solution of chalcone (150 mg, 0.477 mmol) in a 2:1 THF/EtOH mixture (9
mL) was added NaBH4 (36.1 mg, 0.954 mmol)). The mixture was heated to reflux until
completion (1 hour). The solvents were removed and the residue was dissolved in a 1:1
DCM/H2O (10 mL) and was stirred at room temperature. After stirring for 10 minutes the
layers were separated and the aqueous was layer was extracted with DCM (x3). The
combined organic layers was then washed with brine and dried over anhydrous Na2SO4.
Yield: 104 mg, 73 %; yellow oil; 1H NMR (CDCl3; 300MHz) δ 7.37 (d, J = 8.6
Hz, 2H), 6.89 (d, J = 8.8 Hz, 2H), 6.83 (dd, J = 9.9, 1.8 Hz, 1H), 6.01 (s, 2H), 5.78 (dd, J
= 3.5, 1.8 Hz, 1H), 5.60 (dd, J = 9.9, 3.5 Hz,1H), 3.79 (s, 3H), 3.78 (s, 3H), 3.72 (s, 3H).
Synthesis of Diazo

Synthesis of 1-tert-butyl 3-methyl 2-diazomalonate (19a)8

To a solution of tert- butyl methyl malonate (0.97 mL, 5.74 mmol) in acetonitrile
(42 mL), was added p- acetoamidobenzenesulfonyl azide (1.58 g, 6.58 mmol). The
reaction mixture was cooled at 0 oC for 15 minutes, then Et3N (2.7 mL, 19.57 mmol) was
added. The mixture was stirred for an additional 15 minutes at 0 oC before it was warmed
room temperature and stirred overnight. The solvent was removed and the residue was
washed with a 1:1 solution of Et2O/ petroleum ether several times. The solvent was
removed under reduced pressure and the residue was purified by flash column
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chromatography. Yield: 951 mg, 83%; yellow oil; 1H NMR (300 MHz, CDCl3): δ 3.81
(s, 3H), 1.49 (s, 9H).

Synthesis of tert-butyl 2-diazo-2-(diethoxyphosphoryl)acetate (19b)9

To a stirred solution of tert-butyl 2-(diethoxyphosphoryl)acetate (0.1 ml, 0.426
mmol) in dry THF (1 mL) was added a mixture of NaH (12.3 mg, 0.511 mmol) and pacetoamidobenzenesulfonyl azide (123 mg, 0.511 mmol) in THF (1 mL) at 0 oC. The
mixture was stirred for 10 mins at 0 oC and then stirred for an additional 10 min at room
temperature. Ether (2 mL) and water (2 mL) were then added to the reaction mixture and
it was extracted with Et2O. The organic layer as then washed with brine and dried over
anhydrous MgSO4. The solvent was removed under reduced pressure and the residue as
purified by flash column chromatography. Yield: 63.8 mg, 54 %, colorless oil; 1H NMR
(300 MHz, CDCl3): δ 4.23- 4.15 (m, 4 H), 1.50 (s, 9H), 1.39 (t, J = 7.1 Hz, 6H).
Synthesis of cyclopropane 14d

Synthesis of 1-tert-butyl 1-methyl 5,7-dimethoxy-2-(4-methoxyphenyl)1a,2-dihydrocyclopropa[c]chromene-1,1(7bH)-dicarboxylate (14d)7
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To a solution of chromene (175 mg, 0.546 mmol) and Rh2(S-TBSP)4 in DCM (5
mL) was added a solution of tert-butyl methyl malonate diazo (347 mg, 1.73 mmol) in
DCM (3.3 mL) via syringe pump over a period of 3-4 hours. After the addition was
complete the reaction mixture was stirred overnight. The solvent was removed under
reduced pressure and the residue was purified by flash column chromatography using
Et2O/hexane system as the eluent. Yield: 170 mg; 66%; pale yellow oil; 1H NMR (300
MHz, CDCl3): δ 7.82 (d, J = 8.8 Hz, 2H), 6.82 (d, J = 8.7 Hz, 2H), 6.10 (d, J = 2.2 Hz,
1H), 5.84 (d, J = 2.2 Hz, 1H), 5.49 (s, 1H).
Rearrangement of cyclopropane

Synthesis of methyl 7,9-dimethoxy-4-(4-methoxyphenyl)-2-oxo-3,3a,4,9btetrahydro-2H-furo[3,2-c]chromene-3-carboxylate (20)7

To a solution of cyclopropane (51 mg, 0.108 mmol) in dry DCM (2.2 mL) at 0 oC
was added tin(II) triflate (23 mg, 0.054 mmol). The resulting solution was allowed to
warm up to room temperature overnight. It was then quenched with water and the layers
were separated. The aqueous layer was extracted with DCM (x3). The combined organic
layers were washed with brine and dried over anhydrous Na2SO4. The solvent was
removed in vacuo and the residue was purified by flash column chromatography. Yield:
45 mg, 78 %, yellow oil; 1H NMR (600 MHz, CDCl3): δ 7.36 (d, J = 8.6 Hz, 2H), 6.98
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(d, J = 8.6 Hz, 2H), 6.14 (d, J = 2.1 Hz, 1H), 6.10 (d, J = 2.1 Hz, 1H), 5.83 (d, J = 4.8 Hz,
1H), 4.57 (d, J = 11.5 Hz, 1H), 3.86 (s, 3H), 3.84 (s, 3H), 3.76 (s, 6H), 3.29 (dd, J = 11.5,
4.9 Hz), 1H), 3.23 (s, 1H).
Decarboxylation of lactone

Synthesis of 7,9-dimethoxy-4-(4-methoxyphenyl)-3,3a,4,9b-tetrahydro-2Hfuro[3,2-c]chromen-2-one (21)

Procedure A
To a solution of lactone (54 mg, 0.1300 mmol) in DMF (2 mL) was added sodium
iodide (58 mg, 0.387 mmol). Afte refluxing for 5 hours the solvent was removed under
reduced pressure. The residue was then dissolved in water the extracted with EtOAc. The
combined organic layers were washed with brine and dried over anhydrous sodium
sulfate. The solvent was removed and the residue was purified by flash column
chromatography. Yield: 42 mg; 91 %; yellow oil; 1H NMR (600 MHz, CDCl3): δ 7.34 (d,
J = 8.6 Hz, 2H) 6.96-6.94 (d, J=8.6 Hz, 2H), 6.14 (d, J = 2.1Hz, 2H), 6.11 (d, J = 2.1 Hz,
2H), 5.60 (d, J = 4.8 Hz, 1H), 4.55 (d, J=11.5 Hz, 1H), 2.86-2.82 (m, 1H) , 2.78 (dd, J =
17.8, 7.9 Hz, 1H), 2.25 (d, J = 17.8 Hz, 1H); 13C NMR (600MHz, CDCl3): δ 175.4,
162.5, 160.5, 160.2, 157.5, 129.2, 129.1, 114.3, 99.9, 93.1, 92.4, 72.2, 55.8, 55.4, 55.3,
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39.1, 32.4; HRMS (ESI-TOF) m/z: [M+H]+ calcd for C20H21O6, 357.1333; found,
357.1328.
Procedure B
To a solution of lactone (453.6 mg, 1.095 mmol) in anhydrous DMSO (62 mL)
was added NaCl (96.1 mg, 1.643 mmol). After heating the mixture for 1.5 hours, the
mixture was cooled to room temperature and distilled water was added. It was then
extracted with EtOAc (x3) and the combined organic layers were washed with brine and
dried over anhydrous sodium sulfate. The solvent was removed and the residue was
purified by flash column chromatography. Yield: 295.1 mg, 76 %; yellow oil.
Synthesis of α-phosphono lactone 23

Synthesis of diethyl (7,9-dimethoxy-4-(4-methoxyphenyl)-2-oxo-3,3a,4,9btetrahydro-2H-furo[3,2-c]chromen-3-yl)phosphonate (23)

To a solution of lactone (22 mg, 0.0617 mmol) in THF (0.5 mL) at -78 oC was
added LHMDS (0.13 mL, 0.1300 mmol, 1M in THF). After stirring the solution at that
temperature for 2 hours TMEDA (20 µL, 0.13 mmol) and diethylchlorophosphite (20 µL,
0.1390 mmol) was added and the reaction mixture was allowed to warm to room
temperature over 3 hours. The reaction was then quenched by the slow addition of 1 M
acetic acid in Et2O (2 mL). The resulted mixture was filtered through a celite pad and the
65

pad was washed with Et2O. After concentration under reduced pressure the residue was
stirred overnight (the flask was left open to air). The mixture was dissolved in Et2O,
washed with saturated NaHCO3 and brine respectively and the organic layer was dried
over anhydrous MgSO4. The solvent was removed under reduced pressure and the
residue purified by flash column chromatography. Yield: 13 mg, 43 % mixture of
diastereomers; clear oil; 1H NMR (300 MHz, CDCl3): δ 7.37(d, J = 8.7 Hz, 2H), 6.96 (d,
J = 8.6 Hz, 2H), 6.14 (d, J = 2.2 Hz, 1H), 6.09 (d, J = 2.2 Hz, 1H), 5.90 (d, J = 2.1 Hz,
1H), 4.53 (d, J = 5.0 Hz, 1H), 4.17-4.01 (m, 4H), 3.85 (s, 3H), 3.83 (s, 3H), 3.75 (s, 3H),
3.25-3.20 (m, 1H) 2.74 (d, J = 24.7, 1H), 1.31 (t, J = 7.1, 3 H), 1.23 (t, J = 7.0, 3H).
Synthesis of Aldol product 26

Synthesis of 3-(hydroxy(4-methoxyphenyl)methyl)-7,9-dimethoxy-4-(4methoxyphenyl)-3,3a,4,9b-tetrahydro-2H-furo[3,2-c]chromen-2-one (26)

To a solution of lactone (295.1 mg, 0.8276 mmol) in THF (2 mL) was added
LHMDS (1.65 mL, 1.65 mmol, 1 M in THF) at -78 oC. After stirring for 2 hours at that
temperature, p- anisaldehyde (200 µL, 1.65 mmol) was added. The solution was stirred
for an additional 2 hours at -78 oC, after which the reaction was quenched by the addition
of saturated aqueous NH4Cl and warmed to room temperature. The resulted mixture was
then extracted with EtOAc (x3). The combined organic layers were washed with brine
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and dried over anhydrous Na2SO4. The solvent was removed under reduced pressure and
the residue purified by flash column chromatography. Yield: 308.5 mg mixture of
diastereomers, 76 %; clear oil; 1H NMR (600 MHz, CDCl3): δ 6.91 (d, J = 8.3 Hz, 2H),
6.81 (d, J = 8.3 Hz, 2H), 6.65 (d, J = 8.3 Hz, 2H), 6.60 (d, J = 8.3 Hz, 2H), 6.11 (s, 1H),
6.03 (s, 1H), 5.76 (d, J = 5.5 Hz, 1H), 5.31 (s, 1H), 4.33 (d, J = 11.5 Hz, 1H), 3.84 (s,
3H), 3.80 (s, 3H), 3.78 (s, 3H), 3.72 (s, 3H), 2.83 (dd, J = 11.5, 5.5 Hz,1H), 2.46 (s, 1H),
2.25 (d, J = 3.5 Hz, 1H); 13C NMR (600MHz, CDCl3): 177.2, 162.2, 160.8, 159.6, 158.8,
157.3, 132.7, 128.8, 128.1, 125.8, 113.8, 113.7, 100.3, 99.9, 93.0, 92.4, 77.2, 72.9, 72.7,
55.7, 55.3, 55.1, 55.1, 52.5, 39.1; other diastereomer: δ 6.97 (d, J = 7.7 Hz, 2H), 6.95
(d, J = 7.68 Hz, 2H), 6.77 (d, J = 7.7 Hz, 2H), 6.72 (d, J = 7.7 Hz, 2H), 6.10 (s, 1H), 6.04
(s, 1H), 5.50 (d, J = 5.3 Hz, 1H), 4.91 (d, J = 9.0 Hz, 1H), 4.42 (d, J = 10.9 Hz, 1H), 3.84
(s, 3H), 3.83 (s, 3H), 3.80 (s, 3H), 3.72 (s, 3H), 3.22 (s, 1H), 2.59 (d, J = 9.1, 1H), 2.56
(dd, J = 10.8, 5.4 Hz, 1H); 13C NMR (600MHz, CDCl3): 177.0, 162.5, 160.6, 160.0,
159.6, 157.2, 131.7, 129.0, 128.2, 127.6, 114.1, 114.0, 99.7, 93.1, 92.5, 76.7, 72.3, 71.5,
55.8, 55.4, 55.3, 55.2, 51.3, 41.7; HRMS (ESI-TOF) m/z: [M+H]+ calcd for C20H21O6,
493.1857; found, 493.1855.
Synthesis α-benzylidene lactone 24

Synthesis of (E)-7,9-dimethoxy-3-(4-methoxybenzylidene)-4-(4methoxyphenyl)-3,3a,4,9b-tetrahydro-2H-furo[3,2-c]chromen-2-one (24)
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Procedure A
To a solution of aldol product 26 (308.5 mg, 0.6264 mmol) in DCM (4 mL) at 0
o

C was added mesylchloride (98 µL, 1.261 mmol) and Et3N (437 µL, 3.135 mmol). After

stirring at room temperature for 1 hour, the reaction mixture was cooled to 0 oC and DBU
(668 µL, 3.129 mmol) was added. The reaction was warmed to room temperature and
stirred overnight. It was then diluted by the addition of distilled water and the layers were
separated. The aqueous layer was extracted with DCM (x3). The combined organic layers
were washed with brine, dried over anhydrous Na2SO4 and filtered. The solvent was
removed in vacuo and the residue purified by flash column chromatography. Yield: 242.9
mg, 82%; yellow oil. E- alkene: 1H NMR (300 MHz, CDCl3): δ 7.53 (s, 1H), 7.18 (d, J
= 8.6 Hz, 2H), 6.89 (d, J = 8.7 Hz, 2H), 6.59 (d, J = 8.8 Hz, 2H), 6.57 (d, J= 8.6 Hz, 2H),
6.17 (s, 2H), 5.5 (d, J = 4.7 Hz, 1H), 4.59 (d, J =10.8 Hz, 1H), 3.88 (s, 1H), 3.79 (s,1H),
3.77(s, 1H), 3.63 (s, 1H); 13C NMR (600 MHz, CDCl3): 172.0, 162.5, 160.7, 160.3,
159.7, 157.5, 139.8, 131.0, 129.4, 128.2, 126.2, 122.5, 113.6, 113.6, 99.9, 93.1, 92.5,
76.7, 70.1, 55.8, 55.4, 55.2, 55.0, 44.4; HRMS (ESI-TOF) m/z: [M+Na]+ calcd for
C28H26NaO7, 497.1571; found, 497.1623. Z- alkene: 1H NMR (300 MHz, CDCl3): δ 7.66
(d, J = 8.7 Hz, 2H), 7.32 (d, J = 8.5 Hz, 2H), 6.94 (d, J = 8.6 Hz, 2H), 6.83 (d, J = 8.8 Hz,
2H), 6.16 (s, 2H), 5.90 (s, 1H), 5.60 (d, 5.1 Hz, 1H), 4.65 (d, J = 11.0 Hz, 1H), 3.88 (s,
1H), 3.85 (s,1H), 3.81 (s, 1H), 3.78 (s, 1H), 3.23 (dd, J = 11.0, 5.0 Hz, 1H); 13C NMR
(600 MHz, CDCl3): 168.7, 162.4, 160.9, 160.8, 160.0, 157.6, 143.2, 133.0, 129.5, 129.1,
126.1, 121.3, 113.9, 113.5, 100.2, 93.1, 92.6, 77.6, 69.2, 55.8, 55.4, 55.4, 55.3, 48.5.
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Procedure B
To a solution of of aldol product 26 (27 mg, 0.0548 mmol) in DCM (0.5 mL) at 0
o

C was added Et3N (38 µL, 0.2726 mmol) and mesylchloride (9 µL, 0.1096). The mixture

was warmed to room temperature and stirred for 1 hour. It was then quenched by the
addition of distilled water. The layers were separated and the aqueous phase was
extracted with DCM. The organic layer was then washed with brine, dried over
anhydrous Na2SO4 and filtered. The solvent was the removed in vacuo and the residue
dissolved in dry THF (7 mL). Potassium tert-butoxide (19 mg, 0.169 mmol) was then
added and the mixture was refluxed until reaction was complete, as indicated by TLC.
After completion the reaction mixture was diluted with distilled water and was extracted
with EtOAc. The organic layer was washed with brine, dried over anhydrous MgSO4 and
filtered. The solvent was removed in vacuo and the residue was purified by flash column
chromatography. Yield: 16.2 mg, 62 %; pale yellow oil.
Synthesis of diol 32

Synthesis of 3-(3-hydroxy-1-(4-methoxyphenyl)prop-1-en-2-yl)-5,7dimethoxy-2-(4-methoxyphenyl)chroman-4-ol (32)

Red-Al (0.66 mL, 2.046 mmol, 60% weight in toluene) was added dropwise to a
solution of α- benzylidene lactone 24 (242.9 mg, 0.5119 mmol) in THF (4.2 mL) at 0 oC.
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The reaction mixture was warmed to room temperature and stirred for 3 hours. The
reaction mixture was then cooled to 0 oC and a saturated solution of Rochelle’s salt was
added dropwise. The layers were separated and the organic layer was washed with a
saturated solution of Rochelle’s salt. The combined aqueous layers were extracted with
Et2O (x3), followed by washing of the combined organic layers with brine. The organic
layer was dried over anhydrous MgSO4 and the solvent was removed under reduced
pressure. The residue was purified by flash column chromatography. Yield: 203.9 mg (Z
Isomer: 73.5 mg; E isomer: 124.7 mg; mix (5.7 mg), 83 %; clear oil. E Isomer: 1H NMR
(600 MHz, CDCl3): δ 7.11 (d, J = 8.7 Hz, 2H), 7.03 (d, J = 8.3 Hz, 2H), 6.87 (d, J = 8.3
Hz, 2H), 6.82 (d, J = 8.7 Hz, 2H), 6.55 (s, 1H), 6.10 (d, J = 2.2 Hz , 1H), 6.02 (d, J = 2.2
Hz, 1H), 5.35 (d, J = 11.1 Hz, 1H), 5.12 (d, J = 3.3 Hz), 4.11 (d, J = 12.0 Hz, 1H), 3.89
(s, 3H), 3.81 (s, 3H), 3.80 (s, 3H), 3.77 (d, J = 12.4 Hz, 1H), (s, 3H), 3.71 (s, 3H), 3.58
(dd, J = 11.0, 3.42 Hz, 1H); 13C NMR (600MHz, CDCl3): δ 161.4, 159.8, 158.8, 158.5,
155.9, 138.0, 134.8, 130.2, 129.8, 129.5, 129.4, 113.8, 113.7, 105.9, 93.1, 91.7, 75.8,
65.1, 64.1, 60.3, 55.6, 55.3, 55.2, 55.1, 44.3; HRMS (ESI-TOF) m/z: [M] + calcd for
C28H30O7, 478.1992; found, 478.1963.

(Z)-3-(3-hydroxy-1-(4-methoxyphenyl)prop-1-en-2-yl)-5,7-dimethoxy-2(4-methoxyphenyl)chroman-4-ol (32b)
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Z Isomer: 1H NMR (600 MHz, CDCl3): δ 7.35 (d, J = 8.7 Hz, 2H), 7.27 (d, J =
8.8 Hz, 2H), 6.86 (d, J = 8.7 Hz, 2H), 6.82 (d, J = 8.8 Hz, 2H), 6.47 (s, 1H), 5.40 (d, J =
11.2 Hz, 1H), 5.11 (d, J = 3.4 Hz, 1H), 3.88 (s, 2H), 3.85 (s, 3H), 3.77 (s, 3H), 3.77 (s,
3H), 3.74 (s, 3H), 3.15 (dd, J = 11.2, 3.2 Hz); 13C NMR (600MHz, CDCl3): δ 161.5,
159.9, 158.9, 158.7, 155.9, 136.7, 135.3, 130.4, 130.4, 129.5, 129.1, 113.9, 113.5, 105.9,
93.2, 91.7, 75.6, 64.9, 58.2, 55.6, 55.4, 55.2, 52.7; HRMS (ESI-TOF) m/z: [M] + calcd for
C28H30O7, 478.1992; found, 478.1963.
Synthesis of mono (TES) Ether

Synthesis of (E)-5,7-dimethoxy-2-(4-methoxyphenyl)-3-(1-(4methoxyphenyl)-3-((triethylsilyl)oxy)prop-1-en-2-yl)chroman-4-ol (37a)

To a solution of diol 32a (23.3 mg, 0.0487 mmol), in dry DCM (16 mL) at - 78
o

C, was added a solution of TESCl (50 µL, 0.2979 mmol) and 2,6-lutidine (60 µL, 0.5152

mmol) in dry DCM (1 mL) via syringe. After stirring at - 78 oC temperature for 3 hours,
the reaction was quenched by the addition of a saturated solution of aqueous NH4Cl. The
mixture was extracted with DCM (x3). The combined organic layers were washed with
brine and dried over anhydrous Na2SO4. The solvent was removed and the residue was
purified by flash column chromatography. Yield: 23.2 mg, 80%; clear oil; 1H NMR (600
MHz, CDCl3): δ 7.09 (d, J = 8.3 Hz, 2H), 7.04 (d, J = 8.3 Hz, 2H), 6.87 (d, J = 8.4 Hz,
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2H), 6.83 (d, J = 8.4 Hz, 2H), 6.51 (s, 1H), 6.09 (s, 1H), 5.98 (s, 1H), 5.45 (d, J = 11.2
Hz, 1H), 5.14 (s, 1H), 4.73 (s, 1H), 4.33 (d, J = 12.1, 1H), 3.88 (s, 3H), 3.81 (s, 6H), 3.77
(s, 1H), 3.69 (s, 1H), 3.59 (dd, J = 11.3, 1.59 Hz), 0.96 (t, J = 7.9 Hz, 9H), 0.63 (q, J =
7.9 Hz, 6H); 13C NMR (600 MHz, CDCl3): δ 163.7, 162.5, 161.7, 161.2, 158.4, 140.0,
136.3, 133.2, 132.6, 132.4, 132.1, 116.6, 116.5, 109.1, 95.4, 94.4, 77.9, 68.1, 66.1, 58.5,
58.0, 58.0, 47.1, 9.5, 7.0; HRMS (ESI-TOF) m/z: [M +Na] + calcd for C34H44NaO7Si,
615.2749; found, 615.2721.

(Z)-5,7-dimethoxy-2-(4-methoxyphenyl)-3-(1-(4-methoxyphenyl)-3((triethylsilyl)oxy)prop-1-en-2-yl)chroman-4-one (37b)

1

H NMR (600 MHz, CDCl3): δ 7.39 (d, J = 8.6 Hz, 2H), 7.01 (d, J = 8.6 Hz, 2H),

6.89 (d, J = 8.6 Hz, 2H), 6.80 (d, J = 8.4 Hz, 2H), 6.49 (s, 1H), 6.11 (d, J = 2.3 Hz, 1H),
6.08 (d, J = 2.3 Hz, 1H), 5.49 (d, J = 11.5 Hz, 1H), 5.10 (d, J = 2.5 Hz, 1H), 3.99 (s, 2H),
3.86 (s, 3H), 3.80 (s, 3H), 3.78 (s, 3H), 3.68 (s, 3H), 3.69 (s, 1H), 3.28 (dd, J = 11.5, 2.5
Hz), 0.96 (t, J = 8.0 Hz, 9H), 0.62 (q, J = 7.7 Hz, 6H); HRMS (ESI-TOF) m/z: [M +Na] +
calcd for C34H44NaO7Si, 615.2749; found, 615.2721.
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Synthesis of ketone 38

Synthesis of (E)-5,7-dimethoxy-2-(4-methoxyphenyl)-3-(1-(4methoxyphenyl)-3-((triethylsilyl)oxy)prop-1-en-2-yl)chroman-4-one (38a)

To a suspension of mono (TES) ether 37a (24 mg, 0.0405 mmol), and NaHCO3
(119.1 mg, 1.4178 mmol) in dry DCM (11.2 mL) at 0 oC was added DMP (34.3 mg,
0.0809 mmol); in two portions over 15 minutes. After stirring at room temperature for 5
hours the reaction mixture was cooled to 0 oC and quenched by the slow addition of
saturated NaHCO3 (10 mL) and Na2S2O5 (10 mL). The resulting mixture was stirred for 5
minutes at 0 oC and then for 30 minutes at room temperature. The layers were then
separated and the aqueous phase was extracted with DCM (x3). The combined organic
layers were then washed with brine and dried over anhydrous Na2SO4. The solvent was
removed under reduced pressure and the residue was purified by flash column
chromatography. Yield: 18.5 mg, 77 %; clear oil; 1H NMR (600 MHz, CDCl3): δ 7.06 (d,
J = 8.5 Hz, 2H), 6.98 (d, J = 8.5 Hz, 2H), 6.79 (d, J = 8.5 Hz, 2H), 6.78 (d, J = 8.5 Hz,
2H), 6.63 (s, 1H), 6.10 (d, J = 2.1 Hz, 1H), 6.04 (d, J = 2.1 Hz, 1H), 5.49 (d, J = 12.6 Hz,
1H), 4.30 (d, J = 12.6 Hz, 1H), 4.22 (d, J = 13.6 Hz, 1H), 4.19 (d, J = 13.5 Hz, 1H), 3.9
(s, 3H), 3.804 (s, 3H), 3.793 (s, 3H), 3.767 (s, 3H), 0.91 (t, J = 7.9 Hz, 9H), 0.58 (q, J =
7.9, 6H); 13C NMR (CDCl3; 600MHz): δ 190.2, 165.5, 164.8, 162.4, 159.9, 158.4, 134.3,
129.9, 129.8, 129.6, 129.4, 129.3, 113.6, 113.4, 106.2, 93.3, 93.2, 81.9, 64.6, 56.0, 55.5,
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55.3, 55.2, 53.4, 6.7, 4.3; HRMS (ESI-TOF) m/z: [M+H]+ calcd for C34H43O7Si,
591.2773; found, 591.2762.

(Z)-5,7-dimethoxy-2-(4-methoxyphenyl)-3-(1-(4-methoxyphenyl)-3((triethylsilyl)oxy)prop-1-en-2-yl)chroman-4-one (38b)

1

H NMR (600 MHz, CDCl3): δ 7.40 (d, J = 8.6 Hz, 2H), 6.90 (d, J = 8.6 Hz, 2H),

6.89 (d, J = 8.5 Hz, 2H), 6.78 (d, J = 8.6 Hz, 2H), 6.14 (d, J = 2.2 Hz, 1H), 6.09 (d, J =
2.2 Hz, 1H), 6.01 (s, 1H), 5.74 (d, J = 11.1 Hz, 1H), 4.38 (d, J = 12.3 Hz, 1H), 4.35 (d, J
= 12.3 Hz, 1H), 3.88 (s, 3H), 3.81(s, 3H), 3.81 (s, 3H), 3.78 (s, 3H), 3.76 (s, 1H), 0.870.84 (t, J = 7.9 Hz, 9H), 0.54-0.50 (q, J = 7.9 Hz, 6H); HRMS (ESI-TOF) m/z: [M+H]+
calcd for C34H43O7Si, 591.2773; found, 591.2762.
Synthesis of keto-aldehyde 33a

(E)-2-5,7-dimethoxy-2-(4-methoxyphenyl)-4-oxochroman-3-yl)-3-(4methoxyphenyl)acrylaldehyde (33)
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To a solution of ketone (20.7 mg, 0.0351 mmol), in dry DCM (1.2 mL) at 0 oC
was added phosphate pH 7 buffer (0.11 mL) and DDQ (9.6 mg, 0.0423 mmol). The
resulting mixture was warmed to room temperature and stirred until completion as
indicated by TLC (7 hours). The mixture was then quenched by the addition of saturated
NaHCO3. The layers were separated and the aqueous phase was extracted with DCM
(x3). The combined organic layers were washed with brine and dried over anhydrous
Na2SO4. The solvent was removed and the reddish residue was purified by flash column
chromatography. Yield: 12.9 mg, 78 %; clear oil; 1H NMR (600 MHz, CDCl3): δ 9.36 (s,
1H), 7.42 (s, 1H), 7.15 (d, J = 8.1 Hz, 2H), 7.01 (d, J = 8.1 Hz, 2H), 6.86 (d, J = 8.1 Hz,
2H), 6.73 (d, J = 8.1 Hz, 2H), 6.12 (s,1H), 6.10 (s, 1H), 5.96 (d, J = 12.0 Hz, 1H), 4.42
(d, J = 12.0 Hz, 1H), 3.90 (s, 1H), 3.83 (s, 1H), 3.80 (s, 1H), 3.77 (s, 1H); 13C NMR (600
MHz, CDCl3): 194.0, 188.9, 165.9, 165.2, 162.7, 160.6, 159.9, 155.0, 130.2, 129.3,
128.6, 126.8, 114.0, 113.7, 93.5, 93.4, 80.9, 56.2, 55.6, 55.3, 55.2; HRMS (ESI-TOF)
m/z: [M+H]+ calcd for C28H27O7, 475.1751; found, 475.1733.
Synthesis of bis (TES) Ether 40

Synthesis of (E)-((5,7-dimethoxy-2-(4-methoxyphenyl)-3-(1-(4methoxyphenyl)-3-((triethylsilyl)oxy)prop-1-en-2-yl)chroman-4yl)oxy)triethylsilane (40a)
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TESCl (184 µL, 1.0962 mmol) was added dropwise to a solution of diol (124.7
mg, 0.2607 mmol), imidazole (110 mg, 1.6157 mmol), and 4-DMAP (12.7 mg, 0.1039
mmol) in dry DMF (8 mL) at 0 oC. The reaction mixture was then warmed to rt and
stirred overnight. It was then poured into a saturated solution of NaHCO3 and extracted
with Et2O (x3). The organic layer was then washed with brine and dried over anhydrous
MgSO4. The solvent was removed and the residue was purified by flash column
chromatography. Yield: 138.6 mg, 75 %; clear oil; 1H NMR (600 MHz, CDCl3): 7.11 (d,
J = 7.7 Hz, 2H), 6.97 (d, J = 7.8 Hz, 2H), 6.82-6.81 (m, 4H), 6.65 (s, 1H), 5.99 (s, 1H),
5.93 (s, 1H), 5.49 (d, J =11.6 Hz, 1H), 5.22 (s, 1H), 4.73 (d, J = 15.8 Hz, 1H), 3.91 (d, J
= 15.8 Hz, 1H), 3.81 (s, 3H), 3.792 (s, 3H), 3.784 (s, 3H), 3.680 (s, 3H), 3.46 (d, J = 11.6
Hz, 1H), 0.90 (t, J = 7.7 Hz, 9H), 0.85 (t, J = 7.6 Hz, 9H), 0.63-0.53 (m, 6H), 0.463 (q, J
= 7.8 Hz, 6H). 13C NMR (600 MHz, CDCl3): 161.1, 159.8, 157.8, 157.7, 155.9, 139.3,
130.9, 130.8, 129.8, 129.7, 125.1, 113.8, 113.7, 106.8, 92.8, 90.6, 75.3, 64.8, 55.3, 55.2,
55.1, 54.8, 43.7, 6.9, 6.7, 5.0, 4.3; HRMS (ESI-TOF) m/z: [M+Na]+ calcd for
C40H50NaSi2, 729.3613; found, 729.3606.

(E)-((5,7-dimethoxy-2-(4-methoxyphenyl)-3-(1-(4-methoxyphenyl)-3((triethylsilyl)oxy)prop-1-en-2-yl)chroman-4-yl)oxy)triethylsilane (40b)
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1

H NMR (600 MHz, CDCl3): 7.37 (d, J = 8.2 Hz, 2H), 6.91 (d, J = 8.1 Hz, 2H),

6.85 (d, J = 8.2 Hz, 2H), 6.79 (d, J = 8.1 Hz, 2H), 6.40 (s, 1H), 6.07 (s, 1H), 6.02 (s, 1H),
5.615 (d, J = 11.3 Hz, 1H), 5.19 (s, 1H), 4.19 (d, J = 11.3 Hz, 2H), 3.79 (s, 3H), 3.78 (s,
3H), 3.77 (s, 3H), 3.74 (s, 3H), 3.073 (d, J = 11.7 Hz, 1H), 0.86-0.59 (m, 18H), 0.590.532 (m, 6H), 0.50-0.46 (m, 6H). 13C NMR (600 MHz, CDCl3): 160.9, 159.2, 158.1,
157.8, 155.8, 136.0, 132.5, 131.1, 130.1, 129.7, 129.6, 113.4, 113.3, 108.0, 92.9, 90.5,
76.8, 62.4, 61.6, 55.2, 55.1, 54.6, 46.1, 7.0, 6.7, 5.1, 4.3; HRMS (ESI-TOF) m/z:
[M+Na]+ calcd for C40H50NaSi2, 729.3613; found, 729.3606.
Synthesis of E-aldehyde 41a

Synthesis of ((E)-2-(5,7-dimethoxy-2-(4-methoxyphenyl)-4((triethylsilyl)oxy)chroman-3-yl)-3-(4-methoxyphenyl)acrylaldehyde (41a)

To a solution of bis-protected triethylsiyl ether 40a (36.4 mg, 0.0515 mmol) in
DCM at 0 oC was added DDQ (12.8 mg, 0.0564 mmol) and phosphate pH 7 buffer (0.18
mL). The solution was warmed to room temperature and monitored for completion. Upon
completion saturated NaHCO3 was added and the layers were separated. The aqueous
phase was extracted with Et2O (x3). The combined organic layers were then washed with
brine and dried over MgSO4. The solvent was then removed under reduced pressure and
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the residue was purified by flash column chromatography. Yield: 20.7 mg 68 % (79 %)c ;
clear oil; 1H NMR (600 MHz, CDCl3): δ 9.57 (s. 1H), 7.30 (s, 1H), 7.22 (d, J = 8.0 Hz,
2H), 7.18 (d, J = 7.9 Hz, 2H), 6.91 (d, J = 8.3 Hz, 2H), 6.77 (d, J = 7.9 Hz, 2H), 6.14 (d,
J = 11.0 Hz, 1H), 6.05 (s, 2H), 5.20 (d, J = 2.1 Hz, 1H), 3.83 (s, 3H), 3.82 (s, 3H), 3.76
(s, 3H), 3.73 (s, 3H), 3.66 (d, J = 10.9 Hz, 1H), 0.85 (t, J = 8.0, 9 H), 0.62-0.49 (m, 6H);
13

C NMR (600 MHz, CDCl3): 193.0, 161.3, 160.3, 159.7, 159.7, 158.4, 145.2, 131.2,

130.7, 129.6, 114.4, 113.8, 106.3, 92.9, 91.0, 74.8, 64.1, 59.7, 55.3, 55.2, 55.2, 54.7, 6.9,
4.8; HRMS (ESI-TOF) m/z: [M+H]+ calcd for C34H43O7Si, 591.2773; found, 591.2721.
Selective deprotection of 10 TES ether

Synthesis of (Z)-2-(5,7-dimethoxy-2-(4-methoxyphenyl)-4((triethylsilyl)oxy)chroman-3-yl)-3-(4-methoxyphenyl)prop-2-en-1-ol (42)

To a solution of bis (TES) ether (15.1 mg, 0.0213 mmol) in methanol (3.4 mL) at
0 oC was added K2CO3 (23 mg, 0.1664 mmol). The mixture was warmed to rt and stirred
overnight. After stirring overnight, starting material was still present, therefore an
additional K2CO3 (20 mg) was added and the reaction mixture was stirred for an
additional 2 hours. It was then diluted by the addition of distilled water (4 mL) and brine
(4 mL) and extracted with EtOAc (x3). The combined organic layers were washed with
c

Yield based on recovered starting material
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brine, dried over anhydrous Na2SO4, filtered, concentrated under reduced pressure and
the residue was purified by flash column chromatography. Yield: 8.7 mg, 69 %; 1H NMR
(600 MHz, CDCl3): 7.367 (d, J = 8.7 Hz, 2H), 7.09 (d, J = 8.6 Hz, 2H), 6.87 (d, J = 8.6
Hz, 2H), 6.81 (d, J = 8.7 Hz, 2H), 6.46 (s, 1H), 6.07 (d, J = 2.2 Hz, 1H), 6.03 (d, J = 2.3
Hz, 1H), 5.66 (d, J = 11.6 Hz, 1H), 5.22 (d, J = 1.9 Hz, 1H), 4.00 (d, J = 12.2 Hz, 1H),
3.96 (d, J = 12.2 Hz, 1H), 3.81 (s, 3H), 3.78 (s, 3H), 3.78 (s, 3H), 3.75 (s, 3H), 3.02 (dd, J
= 11.6, 1.9 Hz, 1H), 0.87 (t, J = 8.0 Hz, 9H), 0.61-0.57 (m, 3H), 0.54-0.50 (m, 3H); 13C
NMR (600MHz, CDCl3): 161.5, 159.5, 157.8, 156.1, 137.0, 133.6, 130.1, 129.4, 113.8,
113.5, 106.6, 93.0, 90.7, 75.8, 64.1, 60.1, 59.8, 55.3, 55.2, 55.2, 54.8, 51.0, 6.9, 4.9,;
HRMS (ESI-TOF) m/z: [M+Na]+ calcd for C34H44NaSi, 615.2749; found, 615.2721.
Synthesis of Z-aldehyde

Synthesis of ((Z)-2-(5,7-dimethoxy-2-(4-methoxyphenyl)-4((triethylsilyl)oxy)chroman-3-yl)-3-(4-methoxyphenyl)acrylaldehyde (41b)

To a solution of primary alcohol 42 (16 mg, 0.0270 mmol) in DCM ( 0.25 ml) at
rt was added TEMPO (0.42 mg, 0.003 mmol) and BAIB (17.4 mg, 0.0540 mmol). The
reaction mixture was monitored for completion as indicated by TLC (2 hours). The
reaction mixture was then diluted by the addition of DCM and washed with saturated
Na2S2O3. The aqueous phase was then extracted with DCM (x3). The combined organic
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layers were washed with NaHCO3, brine and dried over anhydrous Na2SO4. The solvent
was removed under reduced pressure and the residue purified by flash column
chromatography. Yield: 11.3 mg, 71 %; 1H NMR (600 MHz, CDCl3): 9.59 (s, 1H), 7.61
(s, 1H) 7.29 (d, J = 8.7 Hz, 2H), 7.03 (d, J = 8.6 Hz, 2H), 6.85 (d, J = 8.7 Hz, 2H), 6.82
(d, J = 8.7 Hz, 2H), 6.06 (d, J = 2.3 Hz, 1H), 6.02 (d, J = 2.3 Hz, 1H), 5.55 (d, J = 11.8
Hz, 1H), 5.01 (d, J = 2.2 Hz, 1H), 3.81 (s, 3H), 3.79 (s, 3H), 3.76 (s, 3H), 3.74 (s, 3H),
3.71 (dd, J = 11.8, 2.2 Hz, 1H), 0.83 (t, J = 8.0 Hz, 9H), 0.58-0.47 (m, 6H); 13C NMR
(600MHz, CDCl3): 191.7, 161.1, 160.5, 159.5, 158.0, 155.8, 150.4, 137.0, 131.5, 131.4,
129.5, 126.5, 113.8, 113.8, 106.1, 92.9, 90.8, 76.3, 61.6, 55.3, 55.2, 55.2, 54.7, 40.7, 7.0,
5.0; HRMS (ESI-TOF) m/z: [M+Na]+ C34H43O7Si, 591.2773; found, 591.2721.
Lithiation of aldehyde 41a

(E)-2-(5,7-dimethoxy-2-(4-methoxyphenyl)-4-((triethylsilyl)oxy)chroman3-yl)-1-(2,4-dimethoxy-6-(methoxymethoxy)phenyl)-3-(4methoxyphenyl)prop-2-en-1-ol (42a)

To a solution of aldehyde 41a (24.5 mg, 0.0415 mmol) in toluene (0.3 mL) at – 78
o

C, was added a freshly prepared solution of aryllithium 12d (0.41 mL, 0.303 M in

toluene, 0.1242 mmol). The reaction mixture was stirred at -78 oC for 15 mins and then

d

For preparation of aryllithium see ref.10

80

warmed to -50 oC over 30 mins and then to rt over 2 hours. The reaction was then
quenched by the addition of a saturated solution of NH4Cl and extracted with EtOAc
(x3). The combined organic layers were then washed brine and dried over anhydrous
Na2SO4. The solvent was removed under reduced pressure and the residue purified by
flash column chromatography. Yield: 23.1 mg as a mixture of inseparable diastereomers,
71 %; HRMS (ESI-TOF) m/z: [M+Na]+ calcd for C44H56NaO11Si, 811.3490; found,
811.3447.
Deprotection of TES ether

Synthesis of (E)-3-(3-(2,4-dimethoxy-6-(methoxymethoxy)phenyl)-3hydroxy-1-(4-methoxyphenyl)prop-1-en-2-yl)-5,7-dimethoxy-2-(4methoxyphenyl)chroman-4-ol (49)

To a solution of alcohol 42a (44.2 mg, 0560 mmol) in dry THF (2.8 mL) at rt,
was added TBAF (84 µL, 1.0 M in THF, 0.084 mmol). The reaction mixture was stirred
at rt until completion (1.5 hours). It was then quenched by the addition of a saturated
solution of NaHCO3 and extracted with DCM (x3). The combined organic layers were
then washed with brine, dried over Na2SO4 and concentrated under removed pressure.
The resulting residue was purified by flash column chromatography. Yield: 31.6 mg as an
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inseparable mixture of diastereomers, 84 %; HRMS (ESI-TOF) m/z: [M+Na]+ calcd for
C38H42NaO11, 697.2625; found, 697.2591.
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